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1 IRP TSH іішп - First International Reference Preparation for 
immunoassay of TSH 
2 IRP hMG - Second International Reference Preparation for 
human Menopausal Gonadotropin 
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CHAPTER 1. INTRODUCTION 
The purpose of the investigation reported in this thesis, was 
to elucidate structural and functional properties of human 
luteinizing hormone. 
Luteinizing hormone (LH) is one of the many hormones secreted 
by the pituitary gland. Together with follicle stimulating 
hormone (FSH), also produced by the pituitary gland, and 
chorionic gonadotropin (CG)' produced by the placenta, it 
forms the group of the gonadotropic hormones. From a chemical 
point of view these hormones show great resemblance. They 
consist of a protein part as well as a carbohydrate moiety; 
hence, they are called glycoproteins. A third pituitary 
glycoprotein hormone is thyroid stimulating hormone (TSH). 
A special feature of these four hormones is that they consist 
of two structurally dissimilar subunits. Within a particular 
species one of these, the a-subunit is more or less identical 
in all four with respect to amino acid composition and 
primary structure of the protein part. The other, the 
ß-subunit, varies and is believed to be the hormone-specific 
subunit. In mammals, the main function of the pituitary 
gonadotropins FSH and LH is to regulate the reproductive 
function. More specifically, they control the gonadal 
activity. In the female FSH promotes growth of the ovarian 
follicles, while LH causes ovulation and stimulates 
luteinization of the follicular cells. In the male, the 
target for FSH are the Sertoli cells through which 
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spermatogenesis in the germinal epithelium is initiated; LH 
stimulates the Leydig cells to the production of androgens. 
However, FSH and LH often are considered to be a "gonadotropic 
hormore complex" for the following reasons. (1) By chemical 
means it is very difficult to separate the one from the other; 
usually one regards the purified preparations of the one 
hormone as being "contaminated" by the other. (2)functionally, 
they act in concert to bring about the many facets of what is 
called "gonadal function", esoecially in the control of the 
gonad in the female. 
Notwithstanding the above mentioned complexity, 
conventional hormone research has recognized differing 
functions for these two hormones. As a consequence of these 
known functions bioassays were developed. A bioassay is a 
functional assay, assessing the relative potency of a hormone 
on the basis of its known qualitative effects. Such an assay 
may employ living animals [гп г ^ bioassay) or isolated 
target tissues („к vitro bioassay). It has been recognized 
that the гг гъго bioassay has several advantages when 
compared with the г*· л' о bioassay, e.g. it is less 
cumbersome, shows a greater reproducibility, as well as 
greater sensitivity. Yet, search for new assay methods 
persisted, in particular with the objective to further 
increase the sensitivity. When it was discovered that peptide 
hormones are also immunologically active, assays based upon 
this type of structural activity were developed. In the late 
1950's tne radioimmunoassay (RIA) was introduced by 
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R.S. Yalow and S.A. Berson. This method was a thousand-fold 
more sensitive than the conventional in vivo assay methods 
and moreover was technically relatively easy to perform. The 
RIA is nowadays one of the routine methods of choice, for 
example for clinical purposes. There is, however, a 
fundamental difference between the bioassay and the RIA. 
Bioassays measure the function of a hormone, whereas in the 
RIA the concentration of the hormone itself is measured. It 
has to be kept in mind that for many protein hormones it is 
not yet clear to what extent the biological (B) and 
immunological (I) activities are related. For the time being, 
therefore, В and I have to be regarded as independent 
characteristics of a hormone. In the last decade a type of 
assay has been developed, which is more or less a hybrid 
between the RIA and the in vitro bioassay, namely the 
radioligand assay (RLA). In this assay the hormone is not 
bound to antibodies but to membranes of cells of the target 
organ. Details of these various assays are presented in the 
pertinent chapters of this thesis. 
Apart from the fact that knowledge of human 
gonadotropins has intrinsic scientific value, clinical 
application of such hormones requires the use of highly 
purified human preparations, as comparative studies 
concerning gonadotropic hormones in other vertebrates 
revealed considerable variability in structure and function. 
Although in the past decade a large number of human LH 
preparations have been made, our knowledge of the properties 
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of this hormone is still limted. This situation prompted us 
to undertake an investigation concerning the characteristics 
of human luteinizing hormone. It involved extraction and 
isolation as well as identification of the hormone structure 
and, more importantly, an analysis of its biological and 
immunological properties. 
To carry out these studies, a sufficient amount of LH 
was needed. Human pituitary material is very scarce and, if 
at all commercially available, very expensive. Thanks to the 
cooperation of the Dutch Growth Foundation and through the 
courtesy of Dr. M. Zachmann (Kinderspital, Zürich, 
Switzerland) v/e obtained several batches of crude pituitary 
material containing the glycoprotein hormone fraction. In 
close collaboration with the research group of Dr. G. Hennen 
(Hôpital de Bavière, Liège, Belgium) highly purified LH 
preparations were made. 
The purification procedure is described in chapter 2. 
The characterization of the preparations employing several 
assay methods is the subject of chapters 3 - 8. In chapter 9 
the results obtained with the various methods are compared 
and discussed. 
Part of the results has been published elsewhere 
(Loebsr & Leqwin, 19 /5, Loebep, .'an lOorcneiiberger & Toajin, 
1977). 
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CHAPTER 2. ISOLATION AND PURIFICATION 
2.1. Introduction 
Human pituitary glands usually are collected at autopsy 24 -
48 hours post-mortem and preserved either dehydrated after 
acetone treatment, or frozen. At least six hormones are fairly 
easy to isolate, namely growth hormone (GH), adrenocortico­
tropic hormone (ACTH), prolactin and the glycoproteins LH, FSH 
and TSH. Irrespective of the way of preservation an initial 
separation of the glycoproteins from the other three hormones 
can be achieved by making use of the difference of their 
solubility in alcohol or in salt-saturated solvents. Коепгд & 
King (1950) developed a method of extracting acetone-dried 
glands with a mixture of 1.3 M ammonium acetate buffer pH 5.1 
and alcohol (60:40 v/v) in which only the glycoproteins are 
soluble. From the residue the other hormones can then still be 
extracted. Frozen glands are commonly treated with 0.01 M 
phosphate buffer pH 6.2 (Roos & Gemzell, 1964; Roos, 1967), 
whereby all hormones are extracted; isolation of the glyco­
proteins can then be achieved by fractionated ammonium 
sulphate precipitation (Squire & Li, 1959; Ward, Adams-Mayne & 
Wade, 1961; Rathnam & Saxena, 1970). The next step is the 
separation of the glycoproteins from one another. The easiest 
and most widely used method is chromatography on ion-exchange 
resins, e.g. the carboxymethyl-(CM-) or diethylaminoethyl-
(DEAE-)derivatives of cellulose or Sephadex, Amberlite CG 50 
etc. (Squire & Li, 1959; Steelman & Segaloff, 1959; Ward, 
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McGregor & Grvffin, ISbö; hoods -5 Зг^р.зсп, 19G1, V ¿râ e г a\ 
29C1; Негокегі S Parlou), ІЭСйа; ¡"jriree. But i, & У г^паг, :0С4; 
Rathnam S Ьахепа, 79/0; Forjcspr, Sard, ".Orman, Irygs^cd î 
í'osñj 1974, Sairarì & Li, 19 7 Ь ; Poos, lìyberg, Wide Ά G^'nzel'', 
197b; Clonset, Var Dale", hemen & Lequin, 1975). Methods f o r 
f u r t h e r p u r i f i c a t i o n comprise p r e p a r a t i v e e l e c t r o p h o r e s i s on 
P o l y a c r y l a m i d e g e l or s t a r c h g e l (Li, 1ЭС8; BvLt, Crooke, 
Cunninghari & Wolf, 196a; Roos S Gemell, 1964), g e l f i l t r a t i o n 
on G 100 or G 200 (Bettendorf, Apostolakn s & Voigt, 196?; 
Rebohert & ParloJ, lOCó; Pathnam & Saxena, 19/0) and chromato-
graphy on h y d r o x y l a p a t i t e ("utt, Crooke & Carsingnaw, 1961). 
I t cannot be s t a t e d which method i s t o be p r e f e r r e d , as 
each one y i e l d s more or l e s s "pure" hormone p r e p a r a t i o n s . The 
p u r i f i c a t i o n s c h e d u l e s used fo r t h e p r o j e c t d e s c r i b e d in t h i s 
t h e s i s a r e l a r g e l y t h o s e acco rd ing t o Closset et al (197h). 
2.2. Materials and methods 
Crude glycoprotein material froir acetonp-dned pi tui tary glands was made 
available by the Dutch Growth Foundation. Crude glycoprotein material from 
frozen pi tui tary glands was a gift from Dr. M. Zachnann (Zurich, Switzer-
land). All chemicals were reagent grade mainly from Merck (Darmstadt, 
Germany). Sephadex ion-exchange resins and f i l t ra t ion gels were obtained 
fron Pharmacia (Uppsala, Sweden) and treated as prescribed by tae manu-
facturer. To obtain the protein elution profile of the columns, the 
absorbancy of tne effluent at 235 or 280 nn was measured with a Beekman 
Dual Beam spectrophotometer, or the protein concentration in aliquots of 
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the colunmfractions was determined according to (Mbller (1959). To 
measure the protein content of hormone preparations more precisely the 
method of LaDry, Rosebrough, Farr S Randall (1951) was used with Bovine 
Serum Albumin (BSA, Sigma) as a standard. Fraction volumes were reduced by 
ultrafiltration in Amicon cells supplied with a UM-2 filter. 
2.3. Procedure (fig. 2-1) 
2.3.1. Separation of LH^ . and FSH from LH and TSH 
Crude glycoprotein material from either acetone-dried or frozen 
glands was dissolved in 0.005 M Na-phosphate buffer pH 6.2. Any 
insoluble material was removed by centrifugation. The clear 
brown solution was applied on a CM-Sephadex С 25 column (30 χ 
5 cm), previously equilibrated in the same buffer. The brown-
yellow non adsorbed fraction was collected and the column 
washed till the absorbancy of the effluent at 235 nm (Aj-^ c) was 
lower than 0.05 (fraction C T ) . Next, the column was stripped by 
0.5 M NaCl dissolved in buffer and washed till the Aj-ic of the 
effluent was lower than 0.05 (fraction С--). 
2.3.2.Fractionation of C-; separation of LH_ and FSH 
Solid (NH4)2S04 was added to fraction Cj till 80% saturation. 
The solution was left overnight. The next day the precipitate 
was collected by centrifugation (20 min at 15000 g) and 
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Crude glycoprotein material 
CM-Sephadex; 0.005 M Na-phosphate pH 6.2 
NON-ADSORBED (С ) 
DEAE-Sephadex; 0.0 2 M Na-glycinate pH 9.5 
stepwise elution 
(NaCl dissolved in buffer) 
1. 0.055 
(LU) 
2. 0.075 
(LH + FSH) 
G 100; 0.05 M 
руг. ас. pH 5.0 
LH, 
3. 0.30 M Na 
(FSH) 
G 100; 0.05 M 
Dyr. ас. п^ 5.0 
FSH 
ADSORBED (С ) 
(elution 0.5 M NaCl) 
DEAE-Sephadex; 0.05 M Na-glycinate pH 9.5 
NON-ADSORBED 
(LH) 
G 100; 0.05 M 
NH 4HC0 3 pH 8.0 
LH II 
ADSORBED 
(TSH) 
I 
(elution 
0.25 M NaCl) 
TSH 
Fig. 2-1. Extraction and purification 
of human glycoprotein homones fron 
pituitary material. 
dissolved in 50 ml of distilled water while the supernatant 
was discarded. The solution was desalted by gelfiltration on 
G 25, equilibrated in 0.02 M Na-glycinate buffer pH 9.5 and 
applied on a DEAE-Sephadex A 25 column (20 χ 5 cm) equi­
librated in the same buffer. Under these conditions most of 
the LH and FSH will adhere to the column. The LH, however, can 
be eluted with low ionic strength. To assess which ionic 
strength or molarity of the eluting buffer is optimal for 
separation of the two hormones a pilot study was performed in 
which the DEAE-column was eluted stepwise with small incre­
ments in buffer molarity. The increments were made by adding 
NaCl to the buffer each time after Aj-jj- of the effluent was 
lower than 0.05. By means of specific radioimmunoassay systems 
(chapter 7) the amounts of FSH and LH in each fraction were 
measured (fig. 2-2). it appeared to be impossible to achieve a 
complete separation of the two hormones. However, the pilot 
study indicated that it was possible to obtain relatively pure 
preparations at the expense of losing some material in a mixed 
hormone fraction: elution with 0.055 M Na removed most of the 
LH activity with a minimal amount of FSH activity, increasing 
the molarity of Na to 0.075 M yielded a fraction with both LH 
and FSH activity, while the fraction obtained after having 
increased the Na concentration to 0.3 M contained little LH 
and much FSH activity. The three fractions thus obtained 
(C_A 0.055, C-,Α 0.075, CjA 0.3) were concentrated in an Amicon 
ultrafiltration apparatus. The fraction C-A 0.075 was stored 
at -20 C, the other two were further purified as described 
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Fig. 2-2. Stepwise elution of С adsorbed on DEAE-Sephadex 
A 2 5 in 0.02 M Na-glycinate pH 9.5,by addition of increasing 
amounts of NaCI. LH and FSH activities were measured by 
radioimmunoassay. 
below. 
2.3.2.1. Purification of C A 0.055 
This fraction was further purified by ascending gelfiltration 
on G 100 (300 χ 5 cm) in 0.05 M pyridine acetate pH 5.0. The 
elution profile was monitored both by protein determination 
according to Miller (1959) and by radioimmunoassay. The column 
fractions containing LH activity were pooled; this pool was 
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concentrated by Amicon ultrafiltration and either stored at 
-20oC or lyophilized. LH preparations obtained by this 
procedure will be further referred to as LH... 
2.3.2.2. Purification of C^ -A 0.3 
This fraction was purified as described for C A 0.055. The 
column fractions containing FSH activity were pooled; this 
pool was concentrated by Amicon ultrafiltration and stored at 
-20 C. (Further purification was performed by Closset and his 
co-workers in Liège, Belgium, and will not be described in 
this thesis). 
2.3.3. Fractionation of С ; separation of LH and TSH 
Solid (NH.KSO. was added to fraction CL· till 80% saturation. 
The .solution was left overnight. The next day the precipitate 
was collected by centrifugation (20 min at 15000 g) and 
dissolved in 50 ml of distilled water, while the supernatant 
was discarded. The solution was desalted by gelfiltration on 
G 25 equilibrated in 0.05 M Na-glycinate buffer pH 9.5 and 
applied to a DEAE-Sephadex A 25 column (20 χ 5 cm), equi­
librated in the same buffer. The non adsorbed fraction, which 
is mainly LH, was collected and the column washed till the 
A235 0^ t^ie effl u e nt was lower than 0.05. The total eluate 
(Cj-A 0.05) was concentrated by Amicon ultrafiltration and 
further purified as described below. The molarity of the 
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elutmg buffer was then increased to 0.25 by addition of NaCl 
and the column eluted till Λ^ ,^ . lower than 0.05. This eluate, 
which is mainly TSH, was concentrated by Amicon ultra­
filtration and stored at -20 C. (Further purification was 
performed by Closset and his co-workers in Liège, Belgium 
(Closset, 1375) and will not be described in this thesis) 
2.3.3.1. Purification of C A 0.05 
This fraction was further purified by gelfiltration on G 100 
(100 χ 5 cm) ih 0.05 M NH^HCC^ pH 8.0. The elution profile 
was monitored both by reading absorbancy at 2 80 nm and by 
radioimmunoassay. The fractions containing LH activity were 
pooled and lyophilized. LH preparations obtained by this 
procedure will be further referred to as LH preparations. 
2.3.4. Preparation of LH subumts 
About 50 mg of a purified LH or LH T T preparation was dis­
solved m 10 ni of a solution of 8 M urea in 0.05 M HCl 
pH 2.8. The solution was incubated at room temperature for 
16 - 20 h. The pH of the solution was adjusted to 9.5 with 
1 N NaOH and diluted with 40 ml of 0.01 M Na-glycinate pH 9.5, 
The solution was then quickly applied to a small DEAE-
Sephadex A 25 column (2 χ 10 cm) previously equilibrated in 
the same buffer. The 6-subunit, which was not adsorbed, was 
collected by washing the column. The α-subunit was eluted by 
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application of a lineair gradient of NaCl dissolved in the 
glycinate buffer and ranging from 0 - 0.5 M. Both subunit 
fractions were desalted on G 25, equilibrated in 0.05 M 
NH.HCCu pH 8.0 and lyophilized. Each subunit was submitted to 
the same treatment once more to remove contaminations of the 
other subunit as well as some undissociated LH. Finally, they 
were gelfiltrated on G 100 (2 χ 100 cm) in 0.05 M NH4HC03 
pH 8.0 and lyophilized. 
2.4. Results and discussion 
The described purification procedure was performed eight 
times, six times with material from acetone-dried glands 
yielding the batches coded NM 07, 08, 09, 14, 15, 16 and 
twice with material from frozen glands yielding the batches 
code'd NM 10 and 11. Good separation of major quantities of 
FSH and LH was achieved in all cases. However, the presence, 
after the first chromatography, of a substantial amount of LH 
in the crude FSH-fraction may not be surprising in view of 
similar results reported by other investigators. Usually such 
LH contamination of FSH has been destroyed in the process of 
FSH purification by treatment with chymotrypsin {Reichert, 
196?) or urea (Saxcna & Rathnam, 1968) , partitioning (Butt, 
Crooke & Wolf, 1965) and electrophoresis (Graesslin, Weise & 
Bettendorf, 1972). Because the conditions for separation of LH 
and FSH during fractionation of С on the DEAE-Sephadex A 25 
23 
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Fig. 2-3. Elution profiles of hLH fractions after final gel-
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to Miller (c,d). Broken lines indicate LH activity as determined 
by radioimmunoassay. Hatched bars indicate fractions pooled for 
гті Л vnl imp . U 
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column were unknown, a pilot study was carried out as des­
cribed in section 2.3.2. To be able to evaluate the results in 
a short time specific radioimmunoassays for LH and FSH were 
used in a first instance. By means of in vivo bioassay tech­
niques (chapter 5), however, the separation, based upon the 
results of these RIA's, was confirmed: the final Ш and FSH 
preparations were minimally contaminated by each other. The 
success of isolating this particular LH, called LH , which 
differed from the major fraction of LH (LH T T), points up the 
question whether these two LH forms reflect the existence of 
so-called micro-heterogeneity. This interesting problem will 
be discussed in chapter 9. 
The major drawback of using starting material extracted 
from frozen glands compared with that from acetone-dried 
glands is that the former contains a larger amount of inert 
protein including blood pigments, which are difficult to 
eliminate. Fortunately, because these proteins behave similar 
to FSH on the ion-exchange columns, at least the LH 
preparations are relatively free of them. However,if the final 
G 100 elution profiles are compared (e.g. LH from NM 08 and 
NM 11, fig. 2-3a,b) it is clear that it cannot be decided from 
the protein profile alone in which peak the LH activity 
resides. Once the behaviour of LH on G 100 gelfiltration has 
been established by precise determination of К -values 
av 
(chapter 3) this information could be of use in subsequent 
purification procedures. Another possibility is to measure LH 
activity by radioimmunoassay to distinguish between the 
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σ\ Table 2 - 1 . Ddta concerning hunan pituitary preparations and results of LH purification. 
Batch2' 
NM 07 
08 
09 
14 
15 
16 
10 
11 
Starting 
Initial 
wt (g) 
5.2 
12.2 
8.1 
14.0 
10.0 
17.0 
13.5 
12.5 
material 
Approx. 
no of 
pit. 
glands 
2600 
7600 
8600 
7600 
7000 
5000 
2800 
2600 
Spec.biol. 
act. (IU 
lStIRP LH 
bio/mg 
260 
240 
400 
260 
195 
210 
165 
165 
LHI 
Final 
wt 
(ng) 
16 
47 
72 
13 
66 
10 
26 
Spec.biol. 
act. (IU 
lStIRP LH 
bio/mg 
13700 
7900 
4700 
9450 
3060 
5100 
2940 
Punf. 
factor 
55 
20 
29 
48 
15 
31 
18 
Ш
І І 
Final 
wt 
(mg) 
58 
205 
255 
240 
96 
266 
30 
36 
Spec.biol. 
act. (IU 
lStIRP LH 
bio/ng 
6050 
1490 
4400 
8400 
12500 
9550 
4580 
3700 
Punf. 
factor 
23 
6 
11 
42 
64 
45 
28 
22 
1) For definition of terms, see text. 
2) NM 07 - NM 16: acetone-dried glands; NM 10 - NM 11: fro7en glands. 
hormone and other proteins. This technique has been used here. 
The radioimmunoassay system utilises an antiserum directed 
towards LH -subunits. LH preparations always contain a certain 
ρ 
amount of free subunits which are partially separated from the 
intact hormone by gelfiltration on G 100, due to the difference 
in molecular size. The shoulder in the descending part of the 
peak concerning the immunologically active LH represents the 
ß-subunit contamination. A similar situation holds for LH 
preparations (Fig. 2 - 3c,d). 
In Table 2-1 the quantities of starting material as well 
as the yields in terms of dry weight of both types of LH for 
the various batches are compiled. Although these figures give 
an indication of the efficiency of this schedule, when a 
purification procedure has to be judged for its merits not 
only the quantity of the products has to be taken into account, 
but also the quality. In the case of hormones the quality can 
be correlated to the specific biological activity, i.e. the 
biological activity per unit weight. It is difficult to com-
pare the absolute figures for the biological activities 
attained by one's own procedure with those reported in the 
literature due to variability in bioassays as well as in 
standards and reference preparations used. It is possible, 
however, to state the "purification factor", i.e. the ratio 
of the specific biological activities of the end-product and 
the starting material (Table 2-1). Unfortunately few 
investigators report these factors. 
l)The LH preparations from the batches NM 07 and NM 08 were combined to one 
preparation; in the text and figures this preparation is referred to as NM 0708 . 
27 
Ν) 
CO Table 2 - II. Calculated efficiency of purification of human LH and LH . 
Batch2' 
NM 07 
08 
09 
14 
15 
16 
10 
u 
Starting material 
Total initial biol. 
act. 
(IU lStIRP LH bio) 
1.3 χ 106 
2.6 χ 106 
3.2 χ 106 
2.8 χ 106 
2.0 χ 106 
3.6 χ 106 
2.2 χ 10 6 
2.1 χ 106 
LHI 
Total final biol. 
act. 
(IU 1 S IRP LH bio) 
2.2 χ 10 5 
3.7 χ 10 5 
3.4 χ 105 
1.2 χ 10 5 
2.0 χ 10 5 
5.1 χ IO4 
7.6 χ IO4 
Final act 
Initial act 
in % 
5.2 
8.7 
15.5 
6.0 
5.7 
2.3 
3.6 
Ш
І І 
Total final biol. 
act. 
(IU lStIRP LH bio) 
3.5 χ 10 5 
3.1 χ 10 5 
1.1 χ 106 
2.0 χ 106 
1.3 χ 106 
2.6 χ 105 
1.4 χ 10 5 
1.3.x 10 5 
Final act 
Ini ti al act 
m % 
27.0 
10.7 
35.0 
71.5 
65.0 
71.0 
6.2 
6.5 
Comparable data: Roos et al, 1975 25.0 
Reichert & Parlow, 1964b 50.0 
1) For definition of terms, see text. 
2) NM 0/ - NM 16: acetone-dried glands; Rathnam & Saxena, 1970 75.0 
NM 10 - NM 11: frozen glands. 
Torjesen et al, 1975 19.0 
Fig. 2-4. Schematic illustration of the 
purification procedure of human pituitary 
glycoprotein hormones. At each step hor­
monal activities, determined by radio­
immunoassay, are expressed as percentages 
of the activities (LH, FSH and ΤΞΗ) of 
the starting (crude) material. 
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LH τ 
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To solve the question which purification ipethod is 
quantitatively the most efficient, the activity of the 
punf led preparations should be expressed as a percentage of 
the total activity of the starting material. Table 2 - II 
shows these percentages for biological activity. There is a 
striking distinction between the results of batches ІмМ 10 and 
11 (from frozen glands) and the others. The figures for the 
other batches are similar to those reported by ^eic^ert % 
Parlou f1964b), Ίαζηηαπ S Sagena (13/Q), Ζ or o e sen et al (1974) 
and Roce et al (19/5). 
Finally, to monitor the procedure as a whole, during the 
purification of several batches the immunological LH, FSH and 
ΤΞΗ activities of the mternediate fractions were determined 
and expressed as percentage of the initial activities (Fig. 
2 - 4 ) . The data obtained confirm earlier conclusions that it 
is easier to obtain LH free from FSH than FSH free from LH. 
Also a substantial amount of TSH appears to remain in the FSH 
fraction. These data are all based upon specific RIA systems 
for the different hormones. However, inadvertent measurement 
of α/β-subunits cannot be completely excluded. 
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CHAPTER 3. PHYSICO-CHEMICAL PROPERTIES 
3.1. Introduction 
The two forms of LH isolated differed with regard to their 
behaviour on ionexchange resins, from which it can be deduced 
that their isoelectric points differ. The isoelectric point 
(pi) of a protein has been defined as the pH at which the net 
electric charge of the total molecule is zero and the protein 
has zero mobility in an electrophoretic field. A glycoprotein 
consists of one or several chains of amino acids to which 
carbohydrates (pentoses and hexoses) have been attached. The 
net electric charge of a glycoprotein molecule is therefore 
the resultant of the individual charges of the amino acids 
and those of the carbohydrates. In LH the hexose whose con­
tribution to the electrical charge is the largest, is sialic 
acid, which, moreover, is well-known to be essential for in 
vivo biological activity. A difference in pi between the two 
forms of LH may be caused by differences in amino acid com­
position, by differences in sialic acid content or by both. 
For a complete characterization of the LH preparations, 
determination of pi, sialic acid content and amino acid 
composition were deemed pertinent, particularly with a view to 
gain insight in structure-function relationships. It seemed of 
equal interest to determine whether there is a difference 
between LH and LH T T in molecular size. The mechanism of 
production and secretion of LH by the pituitary gland has 
been the subject of recent studies. Hagen Ά MoNeilly (1975), 
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Prentice & Ryan (1975), Edmonds, Moli toh. Fierce & Odell (1975) 
and Hagen, MoNatty & McNeilZy (1976) have given ev idence t h a t 
a poo l of a - s u b u n i t s i s a v a i l a b l e and t h a t t h e ß - s u b u n i t s a r e 
produced when r e l e a s e i s c a l l e d f o r . Only th rough combinat ion 
of t he two s u b u n i t s a b i o l o g i c a l l y a c t i v e LH molecule i s 
formed. I t may be expec ted t h a t t h e p i t u i t a r y g lands used for 
t h e i s o l a t i o n of LH c o n t a i n e d a t l e a s t a c e r t a i n amount of 
f r e e a - s u b u n i t s . To c h a r a c t e r i z e t he p r e p a r a t i o n s as comple te -
ly as p o s s i b l e t h e s u b u n i t con tamina t ion was , t h e r e f o r e , a l s o 
de t e rmined . 
3 . 2 . I s o e l e c t r i c p o i n t (pi) 
Procedure. An LKB Instruments Inc. Multiphor Polyacrylamide electro-
focussing apparatus was used according to the conditions mentioned in the 
manufacturer's application note nr. 75. Ampholines were purchased from LKB, 
Bromma, Sweden. The components of the Polyacrylamide gel for the pH range 
3.5 - 9.5 consisted of 10 ml acrylamide solution 29.1% w/v, 10 ml NN'-
methylene-bis-acrylamide solution 0.9% w/v, 36 ml sucrose solution 22% w/v, 
2.В ml Ampholine pH 4 - 6, 0.2 ml Ampholine pH 5 - 7 and 0.4 ml ribo­
flavine solution 0.012% w/v. Polymerization was achieved under influence 
of UV l ight . The cathode solution was 1 M NaOH, the anode solution 1 M 
H.,PO„. Electrofocussing occurred for 20 hours at 300 V. At the end of the 
3 4 3 
run the pH gradient obtained was determined as described by Finlayson & 
Chranbach (1971). This consists of freezing and slicing the gel, eluting 
the slices and measuring the pH of the eluate with a pH Radiometer Copen­
hagen. The gel slab was fixed and stained with a modified Coomassie Brillait 
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Blue solution, prepared according to "tolik & Berrie (197?). The LH and 
LH preparations of the batches MM 07 - 11 were investigated. 
Results. In t h e pH range 3.5 - 10 t h e LH p r e p a r a t i o n s showed 
a double band a t pH 5.7 - 5 . 8 ; t h e LH p r e p a r a t i o n s showed 
t h r e e b a n d s , one ma]or band a t pH 8 . 8 , t h e o t h e r two a t pH 
7.9 and 8.4 r e s p e c t i v e l y (Table 3 - 1 ) . The e x p e r i m e n t s were 
r e p e a t e d in o t h e r pH-ranges t o check f o r development of a r t e ­
f a c t s due t o p o s s i b l e i n t e r a c t i o n s between t h e ampholines and 
t h e sample p r o t e i n s (Rezahert, 1Э71) b u t t h e r e s u l t s were 
e s s e n t i a l l y t h e same as b e f o r e . 
Table 3 - 1 . Isoelectric points (pi) and s i a l i c acid content of 
purified human LH and LH . 
Batch1' 
NM 07 
08 
09 
14 
10 
11 
LHI 
pi 
5.7 - 5.8 
5.7 - 5.8 
n.d.3) 
5.7 - 5.8 
5.7 - 5.8 
% sialic 
acid (w/w) 
3.2 
3.1 
3.6 
1.2 
1.5 
2) 
Ш
І І 
pi 
7.9 -
7.9 -
7.9 -
7.9 -
7.9 -
8.4 - 8.8 
8.4 - 8.8 
8.4 - 8.8 
n.d.3) 
8.4 - 8.8 
8.4 - 8.8 
% sialic 
acid (w/w) 
2.1 
2.3 
2.8 
3.0 
1.4 
1.3 
1) NM 07 - NM 14: acetone-dried glands; NM 10 - NM 11· frozen g lands . 
2) P r e c i s i o n of the method, expressed as c o e f f i c i e n t of v a r i a t i o n : 3-5%. 
3) n .d . = not determined. 
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3.3 S i a l i c a c i d 
Fvoaedurp. S i a l i c acid was determined by Lhe t h i o b a r b i t u r i c acid method 
developed by Varier (l?b9). In s h o r t , t h i s Tietnod c o n s i s t s of t r e a t i n g the 
sample with hot d i l u t e d su lphur ic acid t o I n b e r a t e the s i a l i c ac id , 
oxidiz ing i t by p e r i o d a t e ard coupling by t h i o b a r b i t u r _ c ac id . The 
r e s u l t i n g chrorophore i s then ex t rac ted in cyclohexanone and determined 
q u a n t i t a t i v e l y by spectroiretry a t 549 nm. The LH and ЬН p r e p a r a t i o n s 
of the oatches NM 07 - 14 were i n v e s t i g a t e d . 
Pes 'L's. (Table 3 - 1 ) I t appears t h a t m t h e case of a c e t o n c -
d r i e d m a t e r i a l (NM 07, 08, 09 and 14) t h e s i a l i c a c i d c o n t e n t 
was h i g h e r i n t h e LH p r e p a r a t i o n s than i n t h e LH p r e ­
p a r a t i o n s , whi le t h a t of t h e two LH p r e p a r a t i o n s d e r i v e d from 
f rozen m a t e r i a l (NM 10, 11) was more or l e s s e q u a l . 
3 .4 . Ammo a c i d a n a l y s i s 
FvocediZre. For p r a c t i c a l reasons oily one p r e p a r a t i o n of еаст of the four 
kinds (LH and LH , prepared from actone-Cned glands; LH and LH , 
prepared from frozen glands) was analysed. In a d d i t i o n , the ammo acid 
compositior of the a- and ß-subunits of LH and LH from acetone-dr ied 
glands were dé te rminée The following p repara t ions were chosen. NM 14 , 
NM Ol , NM 11 and NM ! ! „ , аь well as tne subunits of NM 14 and NM 01 . 
After in vacuum hydrolys i s of the p r o t e i n s in 6 N HCl, amno acid compo­
s i t i o n s were determined according t o opoas^-ir, Зівгп 4 "oore r13i-3) using 
1) The s i a l i c acid d e t e r r i i n a t i o r s were k i r a l y c a r r i e d out by I r .J .A.Bakker 
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a Beekman amino ac id analyzer model 121. 
Results. (Table 3 - I I ) The d a t a for NM 01 and i t s s u b u n i t s 
have been p u b l i s h e d e a r l i e r (Closset^ Van Dalem, Hennen & 
Lequin, 1975). The p r e l i m i n a r y r e s u l t s of t h e o t h e r p r e ­
p a r a t i o n s i n d i c a t e t h a t t h e LH p r e p a r a t i o n s c o n t a i n more 
a s p a r t i c a c i d and g l u t a m i c a c i d b u t l e s s p r o l i n e and a r g i n i n e 
t h a n t h e c o r r e s p o n d i n g LHT T p r e p a r a t i o n s . I n s p e c t i o n of t h e 
f i g u r e s for t h e s u b u n i t p r e p a r a t i o n s s u g g e s t s t h a t t h e above 
d i f f e r e n c e s a r e t o be a t t r i b u t e d t o d i f f e r e n c e s i n t h e com­
p o s i t i o n s of t h e a - s u b u n i t s more t h a n t o t h o s e of t h e 0-sub-
u n i t s . 
Table 3 - I I . Amino acid a n a l y s i s of p u r i f i e d human LH and ІЛ 
and t h e i r s u b u n i t s . 
Batch2' 
NM 14 
NM 01 
NM 14 α 
NM 01 α 
NM 14 β 
NM 01 В 
NM 11 
NM 1 1 ^ 
Arg 
4.7 
6.3 
3.4 
5.θ 
9.5 
8.9 
4.2 
4.3 
(Res/lOO res) 
Asp 
9.5 
7.0 
9.5 
5.5 
6.5 
6.2 
9.1 
θ.4 
Glu 
10.9 
8.8 
11.6 
10.4 
8.3 
7.1 
11.2 
9.2 
Pro 
7.7 
13.4 
4.9 
7.8 
15.0 
15.1 
7.3 
7.5 
1) Only va lues , showing s i g n i f i c a n t d i f ferences between i n t a c t 
LH and LH are p r e s e n t e d . 
2) NM 14 - NM 0 1 : acetone-dr ied g lands; NM 11: frozen g lands . 
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3.5. Estimation of molecular size 
It has been shown that during gelfiltration of proteins the 
elution volume, i.e. the amount of effluent measured from the 
application of the sample to the elution of the substance in 
maximal concentration, is approximately a lineair function of 
the logarithm of the molecular weight (Andrews, 1964, 1965). 
Laurent & Killander (1964) developed a mathematical formula 
to obtain the value for the partition coefficient (K ), as 
defined by Andrews (1964) as follows: К =(V -V )/(V,-V ), 
av e o ti о 
where V = e l u t i o n volume of t h e p r o t e i n , V = vo id volume of 
e
 Γ
 о 
t h e column, V,= t o t a l volume of t h e column. By p l o t t i n g t h e 
l o g a r i t h m of t h e m o l e c u l a r weight of known s t a n d a r d p r o t e i n s 
a g a i n s t t h e c o r r e s p o n d i n g v a l u e f o r К a s t a n d a r d curve i s 
o b t a i n e d . From t h i s curve and t h e v a l u e f o r К f o r an un-
known p r o t e i n i t s approximate m o l e c u l a r weight can be d e r i v e d . 
Procedure, The final step in the purification of the LH preparations was 
ge l f i l t ra t ion on Sephadex G 100 (chapter 2). The columns had been ca l i ­
brated beforehand by determimrg the void volume and tota l volune. The 
void colume was taken as the elution volume of a 0.1% Blue dextran 
solution, reading absorbancy at 540 nm, the tota l volume as the elution 
volume of a 0.5 M NaCl solution, reading conductivity with a conductivity 
Radiometer, Copenhagen. The elution volume of the LH preparations was 
derived from the elution profile as monitored both by protein determination 
and radioimmunoassay (Fig. 2-3). 
Result s.The v a l u e s f o r Κ , a l t h o u g h s u b 3 e c t t o some v a r i a t i o n , 
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a r e h i g h e r f o r LH p r e p a r a t i o n s (mean + SE: 0.40 + 0.01) t h a n 
f o r LH j . p r e p a r a t i o n s (mean + SE: 0.25 + 0 . 0 1 5 ) . (Table 3 - I I I ) 
Table 3 - I I I . P a r t i t i o n c o e f f i c i e n t (K ) for column chromatography 
(Sephadex G 100) and subunit contamination for p u r i f i e d 
human LH and L H . 
Batch1' 
NM 07 
08 
09 
14 
15 
16 
10 
11 
LHI 
к 
av 
0.40 
0.41 
0.41 
0.40 
0.42 
0.34 
0.41 
% oc-subunit 
(w/w) 
14.5 
8.0 
12.1 
39.0 
20.4 
12.0 
17.0 
% ß-subunit 
(w/w) 
9.0 
6.0 
7.2 
16.0 
17.5 
9.0 
10.0 
ω
ιι 
к 
av 
0.18 
0.26 
0.19 
0.25 
0.30 
0.28 
0.27 
0.27 
% a-subunit 
(w/w) 
40.7 
39.8 
32.8 
18.2 
8.4 
4.7 
7.6 
2.5 
% ß-subunit 
(w/w) 
10.2 
11.6 
8.9 
1.5 
3.3 
2,3 
4.1 
1.8 
1) NM 07 - NM 16: ace tone-dr ied g lands; NM 10 - NM 11: frozen g lands . 
From the standard curve presented by the manufacturer of 
Sephadex, quoted to be taken from Andrews (1964), the 
molecular weights are estimated to be roughly 30000 for LH 
and 50000 for LHTT. According to Andreus (1985) the values 
for glycoproteins usually are overestimated due to the fact 
that glycoproteins do not have a strictly globular form; 
consequently, the precise molecular weights of the LH pre-
parations remain to be determined. 
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3.6. Subunit contamination 
Subunits can only be measured by radioimmunoassay, since they 
are not active in either the bioassay or the radioligand assay 
Direct measurement of the subunit content of an LH preparation 
is impossible because intact LH cross-reacts in systems em­
ploying antibodies against the individual subunits. It is im­
perative, therefore, to separate the subunits from the intact 
hormone. The difference in molecular weight makes a partial 
separation by G 100 gelfiltration possible. When the activity 
of the column fractions has been determined m the radio­
immunoassay systems specific for LH and LH„, the elution 
profile can be drawn. This is illustrated in Fig. 3 - 1 
(lower part). Due to the above-mentioned differences in 
immunoactivity between intact LH and its subunits in their 
respective systems simple comparison of the areas under the 
peaks of intact hormone and subunit would lead to erroneous 
conclusions. This problem can be solved by comparing the 
elution profiles of an LH preparation with that of a highly 
purified subunit preparation. The area under the peak of the 
subunit preparation is put to 100%; the area under the second 
(= subunit-)peak of the intact preparation is then calculated 
relative to this figure. 
Procedure. One \ig of each LH and ІЛ preparation and of highly purified 
LH and LH. preparations, dissolved in 0.02 M PBS + 0.1% BSA, were applied 
to a Sephadex G 100 column (2 χ 100 cm) equilibrated in this buffer. The 
immunological activity in the column fractions was determined by specific 
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LHa (ng/ml) 
125 J. LH 1 2 S I - L H a 
LHC 
50 60 70 80 90 
fraction number 
Fig. 3-1. Determination of subunit contamination 
by gelfiltration on G 100. As an example, the 
elution profiles of NM 09 (lower part) and 
highly purified hLH (upper part), as assessed 
by a specific hLH radioimmunoassay system, are 
shown. Hatched areas were taken for calculation. 
See text for more details. 
LH and LH radioimmunoassay systems (Table 7 - I). An example of the 
a ρ 
elution profiles thus obtained is shown in Fig. 3-1. Because the 
difference between the molecular weight of the intact hormone and that 
of the subunits is not sufficient for a complete separation, to calculate 
the area under the subunit peak the descending part was taken and multi­
plied by 2, assuming the peak to be symmetrical. 
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Results. The percentages for a- and fi-subunit contamination 
are presented in Table 3 - III. It is evident that the values 
for the a-subunit are higher than those for the S-subunit, 
both in the LH and LHTT preparations. As it is well-known 
that the molecular weights of the subunits are approximately 
the same, our findings are in agreement with the concept that 
in the in vivo situation a pool of o-subunits is available, 
while the S-subunits are produced when LH-release is called 
for (Hagan & Moïeilly, 19'/Ь; Prent ice -S Ryan, 197h; Edmonde 
et al, 1975; Hagen et al, 1976). The values obtained in this 
study, however, unlikely represent the in vivo condition of 
the pituitary gland, since a degree of dissociation post­
mortem cannot be excluded. The results obtained here indicate 
that with regard to subunit contamination, apart from batch-
to-batch variations, on the average no difference exists 
between LH and LH . Furthermore, when the figures concerning 
the acetone-extracted material (NM 0 7 - 0 9 , NM 14 - 16) are 
compared with those concerning the frozen material (NM 10, 11) 
no significant difference appears to exist. Thus, the results 
do not point to an effect of the manner of preservation of the 
tissue. 
3.7. Discussion 
The results of divergent experiments were reported in this 
chapter. Of the various analyses, the pi determination and 
the estimation of the molecular size in particular indicate 
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that there are differences between LH- and LH . Moreover, the 
results concerning the amino acid composition and sialic acid 
content are in direct agreement with those of the pi analysis: 
They all point to the fact, that LH,, is of a more acidic 
nature than LH . From the isoelectric focussing studies it 
also can be inferred that none of the preparations investi-
gated was completely homogeneous. One could argue that the 
finding of several bands reflects the presence of intact 
hormone and free subunits. In that case the intensity of the 
presumed subunit bands would have varied with the degree of 
contamination. Although no quantitative analysis of the bands 
was made, such variation was at first glance not as obvious as 
one would expect on the basis of the large differences in sub-
unit contamination (see Table 3 - III) . Moreover, the LH 
preparations showed only two bands at pH values much lower 
than those for LH . From the amino acid analysis it could be 
concluded that the differences in composition between LH and 
LHJJ mainly are to be attributed to differences in the amino 
acid composition of the respective a-subunits. .As no appreci-
ble differences in amino acid composition between the ß-sub-
units were found, one would expect to find bands representing 
the ß-subunits at approximately the same pH-values for both 
LHj and LHj . Since no such comparable bands could be detected, 
however, the appearance in the gel of subunits as separate 
bands is highly unlikely, at least for the ß-subunits. It is 
more likely that the multiplicity of bands is caused by the 
presence of several molecular forms with a varying sialic acid 
content (of. Reichert, 1971) . Coming now to the amino acid 
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compositions themselves, it should be realised that, although 
the observed differences arc interesting, it is too early to 
draw conclusions. Firstly the preparations from acetone-dried 
glands were not from the same batch and, secondly, the figures 
for LH and LH might be influenced by (varying) amounts of 
contaminating subumts. Yet, the preparations from frozen 
glands which were from the same batch (NM 11) and, moreover, 
contained less subumts, showed also differences, albeit to a 
lower degree. 
Further evidence that LH and LH are different entities 
stems from the gelfiltration studies. Since the reported К 
values are those for the intact LH molecules, in this case 
disturbing influence of cortaninatmg subumts is excluded. 
The difference in molecular size between LH and LH might 
have several causes e.g. the secretion of several molecular 
forms of LH by the pituitary gland during life, or it might be 
brought about by the splitting off of part of the molecule 
induced by either post-mortem proteolysis or by conditions of 
preservation of the glands. By determination of the primary 
structure of the protein chain of LH. this and a number of 
other questions could be elucidated. Unfortunately, structure 
determination consumes a large amount of each preparation. 
Until now, a sufficient quantity of LH prepared from one 
single batch of pituitary glands was not available. 
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CHAPTER 4. GENERAL CONSIDERATIONS ON HORMONE ASSAYS 
As mentioned in chapter 1, in this investigation four differ-
ent assay methods were used to characterize the LH prepara-
tions, namely the in vivo bioassay, the in vitro bioassay, 
the radioimmunoassay (RIA) and the radioligand assay (RLA). 
In this chapter attention is paid to differences and resem-
blances between them with regard to particular requirements 
and procedure, as well as concerning analysis of their 
results (Table 4-1). 
Table 4-1. Comparison of characteristics of four different 
hormone assay methods. 
Methods 
Characteristics 
Standard 
hormone 
Unknown 
preparation 
Labelled 
hormone 
Level of 
target 
Measurement 
of effect 
In vivo 
bioassay 
+ 
+ 
_ 
animal 
indirect: 
by separate 
method 
In vitro 
bioassay 
+ 
+ 
_ 
organ/tissue 
indirect: 
by separate 
method 
RIA 
+ 
+ 
+ 
antibody 
molecule 
direct 
RIA 
+ 
+ 
+ 
cell 
membrane 
direct 
The starting point for all four methods is the comparison of 
the responses elicited by a standard hormone preparation and 
those of an unknown preparation. Thus, the potency of the 
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unknown preparation is expressed in terms of the standard. In 
the in vivo and in vitro bioassay the response is a certain 
change within the test animal (in vivo bioassay) or within the 
isolated target organ {in vitro bioassay) and subsequently is 
measured by a separate appropriate method. In the RIA and RLA 
the response is based on the capability of both the standard 
and the unknown preparation to compete with a labelled hormone 
for binding sites. In the RIA these binding sites are on the 
antibodies, in the RLA, they are present on the membranes of 
the target organ cells. In either case the response is 
measured directly. For analysis of results the responses 
measured must be correlated in some way to the dose of 
hormone used. The ultimate mathematical expression of this 
dose-response relationship may vary with the assay method,but 
to simplify calculation of potencies of unknown preparations 
as well as estimation of the error of the method, ore strives 
for a relationship, which is linear over at least part of the 
dose range. All hormone assays are based upon the assumption 
that the standard and the unknown preparations behave 
identically, i.e. as if they were dilutions of each other 
(Bangham & Cotes, 1971, 1Э74). Therefore, after having 
established the regression lines for the standard and unknown 
preparations, the parallellism of these lines must be inves­
tigated statistically. Whereas parallellism of the regression 
lines is only an indication of identical behaviour, non-
parallellism is proof of non-identical behaviour. From the 
distance between the lines, measured along the dose-axis the 
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potency of the unknown preparation relative to the standard, 
can be computed. 
Apart from parallellism each method has to be tested for 
its reliability. In general, reliability consists of four com-
ponents namely accuracy, precision, specificity and sensi-
tivity (Borth, 1957). 
Aaauvaçy is defined as the nearness with which a given 
analytical result approaches reality. It cannot be measured 
for assays of crotein hormones, because the exact molecular 
hormone concentration is not known. This, in contrast to 
assays of e.g. steroid hormones where absolute concentrations 
can be determined by methods like gas-chromatography and mass-
spectrometry. 
Precision may be defined as the standard deviation from the 
mean value of a series of determinations. Gaddum (19 33) intro-
duced the index of precision, λ, which is defined as the 
standard deviation from the mean of all responses (s) devided 
by the slope of the regression line (b). The precision is 
high when s is small and b is large, i.e. when λ (=s/b) is 
small. To give an impression of the order of magnitude, by 
experience the value of λ for an in vivo bioassay should not 
exceed 0.3, for a RIA λ should not exceed 0.1. Another way to 
obtain an impression of the precision of an assay is to 
calculate the fiducial limits, i.e. the upper and lower 
limits of the range within which the calculated mean lies 
with a certain probability. The smaller the range, the higher 
the precision. Usually the fiducial limits are calculated for 
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the 95% probability level. The mathematics are not as simple 
as in the case of λ and may be obtained from standard text­
books e.g. Evmens (1948), b^nvey (19C4), t/cArthur S Colton 
(1970) . 
Specificbty is defined as the determination of one particular 
entity to the exclusion of others. For protein hormones this 
component is probably the most complex one. For details con­
cerning specificity for each of the four methods used, the 
reader is referred to the appropriate chapter. 
There exists disagreement as to how to define sensitivity. 
Some investigators define sensitivity as the slope of the 
standard curve, others as the minimal detectable dose. 
Sensitivity in either sense is an important concept wher 
samples which have a minimal hormone content must be measured. 
In the present investigation, however, the hormone concen­
trations in each preparation were comperatively high and, 
thus, the sensitivity of the assay methods used was of lesser 
concern. 
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CHAPTER 5. Z7/ VIVO BIOLOGICAL ACTIVITY 
5.1. Introduction 
A hormone essentially is defined by its biological effects in 
the living organism. A bioassay is an assay based upon these 
effects with the purpose to assess the potency of any 
preparation of the hormone in comparison with a standard 
preparation of the same hormone. There are two types of bio-
assays: (1) those based on quanta! effects whereby the end-
point concerns an all-or-nothing effect, e.g. survival or 
death, weight increase above a certain level etc.; (2) those 
based on graded effects whereby the effects can be quantified 
e.g. body weight, organ weight, number of cells produced etc. 
In this investigation only bioassays of the second type have 
been applied. When carrying out these assays known quantities 
of both the standard and the test preparations are administer-
ed, the effects are measured and dose-response curves are con-
structed. 
5.2. Survey of the most common in vivo bioassays for LH and FSH 
5.2.1. Bioassays specific for LH 
Greep, Van Dyke & Chou (1941) reported a method based upon the 
LH-induced enlargement of the ventral prostate in hypophys-
ectomised, immature male rats (VPW-test). Watts S Adair (1946) 
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used the LH-induced weight increase of the seminal vesicles in 
hypophysectomised, immature male rats (SVW-test). Although 
this assay is less sensitive than the VPW-test, it has the ad-
vantage that it can also be carried out with intact immature 
rats (Diczfalusy & Lorraine, ÌOùS; Van Hell, Matt-hijsen S 
Overbeekj 1964). Diczfalusy (1954) introduced a test based 
upon the fact that LH causes a weight increase of the total 
accessory reproductive organs in intact immature rats (WITARO-
test) . Parlo'J (1361) used the ovarian ascorbic acid depletion 
(OAAD) by LH in immature pseudo-pregnant female rats as an 
end-point. In this assay pseudo-pregnancy is induced by pre-
treatment with PMS and hCG. 
There is a distinction between the VPW-, SVW- and WITARO-
testson the one hand and the OAAD-test on the other: the 
latter is an acute assay in which the effect of a particular 
dose of hormone is measured after a limited period of time 
(a few hours); the former are chronic assays in which the 
hormone is administered in several dosages over an extended 
period of time (days) and the effect is measured still later. 
As a consequence, hormone preparations which are metabolized 
quickly often have an apparent higher potency in the acute 
assay than in the chronic assay. 
5.2.2. Bioassays specific for FSH 
Steelman & Pohley (1953) developed a method upon the ovarian 
weight increase induced by FSH and augmented by hCG in intact 
immature rats (AOW-test). Brown (1955) modified this assay 
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f o r a p p l i c a t i o n i n m i c e . 
5 . 2 . 3 . Assays f o r t o t a l g o n a d o t r o p i c a c t i v i t y 
Klinefelter, Albright & Griswald (1943) f i r s t d e s c r i b e d a 
method t o t e s t t o t a l human u r i n a r y g o n a d o t r o p i n s p o s s e s s i n g 
b o t h LH and FSH a c t i v i t y whereby t h e u t e r i n e we ight i n c r e a s e 
of i n t a c t immature mice was measured. Thi s t e s t i s now known 
as t h e Mouse u t e r u s t e s t f o r GSH (=gonad s t i m u l a t i n g hormone) 
t o i n d i c a t e t h a t n e i t h e r LH nor FSH i s measured s p e c i f i c a l l y . 
5.3. Bioassays used in this investigation 
For LH the OAAD-method (Paridi}, 1961) was used; some preparations were 
also assayed with the SVW-test (Van Hell et al, 1964) . The OAAD-method 
was carried out as follows. Immature female Wistar r a t s , 27 days old and 
weighing 40 - 50 g, were obtained from the Central Ins t i tute for the 
Breeding of Laboratory Animals (TNO, Zeist, the Netherlands). They were 
β 
pretreated with PMS (Gestyl , Organon) injected subcutaneously (s.с.) in 
a dose of 50 IU in 0.2 ml distilled water + 0.1% BSA (Sigma), followed 
65 hours later by hCG (Pregnyl , Organon) 25 IU in 0.2 ml distilled water 
+ 0.1% BSA (Sigma). The purpose of the pretreatment with these hormones 
is to induce pseudo-pregnancy and to increase and maintain the ovarian 
ascorbic acid content. The significance of this increase is to enhance 
the sensitivity of the assay: the higher the ascorbic acid level, the 
smaller the amount of LH that causes a measurable ascorbic acid depletion. 
In a pilot experiment it could be shown that the increased ascorbic acid 
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level was maintained from the 4th to the 9th day after the hCG injection. 
Therefore, on the morning of extier tne 5th or 6th or 7th day after hCG 
injection tne animals were injected intravenously (i.v.) with standard LH 
or test material dissolved in saline + 1% BSA (Sigma). Exactly 4 hours 
after this injection each rat was billed after ether anaesthesia, the 
right-hand ovary was carefully dissected out, weighed and boirogenized m 
10 ml icecold 2.5% metaphosphoriс acid (MPA). The homogenate was filtered 
twice through Whatman paper no 41. The filtrate was kept frozen. The 
ascorbic acid concentration was determned by a modification of the method 
of Чігісііъп S Butler (1Эс8), using as reagents 2,6-dichloroindophenol 
(DCIP; 49.2 mg/1) ,and Na-acetate (45.3 g/1) , adjusted to pH 7.0. Equal 
volumes of the two reagertb were mixed immediately before use and kept 
cold. Five ml of this mixture was added to 3 ml of the filtrate and mixed 
during 30 s. The absorbancy at 515 nm was read on a Coleman Junior 
spectrophotometer witn MPA as a blank. A calibration curve of ascorbic 
acid was made as follows: a stock solution of ascorbic acid in MPA 
0.1 mg/ml was diluted to contain 3, 6, 12 and 24 yg/ml resp. Three ml of 
each of tnese solutions were mixed with the DCIP-acetato reagent and the 
absorbancy measured was plotted versus the ascorbic acid concentration. 
The ascorbic acid content of each filtrate was computed and expressed per 
unit ovarian weight. Dose-response curves were constructed by plotting the 
log dose versus the ascorbic acid content in pg per 100 mg ovarian weight. 
The SVW-method was carried out as follows· immature male Wistar rats, 
approx. 25 davs old and weighing 35 - 45 g, were obtained from the Central 
Laboratory for the Breeding of Laboratory Animals (TNO, Zeist, the Nether­
lands). They were injected s.c. with standard or test material dissolved 
in saline + 1% BSA (Sigma) orce per day always at the same tine on three 
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consecutive days. On the fourth day the animals were killed, the seminal 
vesicles were carefully dissected out and weighed. Dose-response curves 
were constructed by plotting tne log dose versus the seminal vesicle 
weight. 
Έον FSH the ovarian augmentation test (AOW-test) as described ay Steelnan 
& Pohley (1953) was used. Immature female Wistar rats, approx. 25 days 
old and weighing 30 - 40 g, were obtained from the Central Laboratory for 
the Breeding of Laboratory Animals (TNO, Zeist, the Netherlands). They 
were injected s.c. 6 times on three consecutive days (once on the first 
day: at 3 p.m.; three times on the second day: at 9 a.m., noon and 3 p.m. 
and twice on the third day: at 11 a.m. and 3 p.m.) with 3 doses of 
standard or test material dissolved in 0.02 M phophate buffer pH 7.1 + 
β 
1% BSA (Sigma). This last buffer also contained hCG (Pregnyl , Organon) 
in such a concentration tnat each animal received a total of 60 IU 
(established in pilot experiment). Litter-mates were used whenever 
possible. The injection schedule was such that one animal of each pair of 
litter-mates received a dose of the standard preparation and the other one 
a corresponding dose of the test solution. Since a pilot study had shown 
that the slope of the dose-response curve was maximal when the ovarian 
weights were determined approximately 45 hours after the last injection, 
in all experiments the rats were killed on the fifth day after the first 
injection and both ovaría were carefully dissected out and weighed. Dose-
response curves were constructed by plotting the log dose versus the 
ovarian weight. 
Calaulation of btologiaal activity; reference preparations 
In each assay a local standard was used after calibration against the 
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M Table 5 I. Potencies of human LH and LH determined by ъп VIVO bioassay (OAAD) 1) 
Batch ' 
NM 0 7 
08 
09 
14 
15 
16 
10 
И 
ш
і 
zu 1 s t 
(mean; 
11580 
15690 
7010 
8060 
3570 
5760 
9420 
3070 
5130 
2940 
IBP LH/FSH bio/mg 
95% fiducial 
( 6370-35190) 
(10510-26810) 
( 5200-10440) 
( 5640-12840) 
( ?300- 5800) 
( 3320-12620) 
( 6920-13280) 
( 1800- 4530) 
( 2410- 6890) 
( 1380- 4890) 
Combination 07-16: 
10-11: 
limits) 
13650 
7860 
4690 
} 9420 
j 3070 
j 5130 
j 2940 
7400 
4280 
(10330-
( 5390-
( 3320-
( 6920-
( 1800-
( 2410-
( 1380-
( 6370-
( 2830-
25670) 
11370) 
6930) 
13200) 
4530) 
6890) 
4890) 
8710) 
6150) 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
28 
24 
17 
20 
24 
35 
18 
23 
19 
23 
L H I I 
IU l S tIRP LH/FSH b 
(mear 
8590 
3990 
6140 
1690 
1380 
2470 
4280 
4520 
9250 
8370 
12560 
9550 
4580 
3230 
3740 
; 95% fiducia 
(1500-37820) 
(1490- 8200) 
(4420- 8890) 
( 280- 3390) 
( 130- 2980) 
( 910- 6300) 
(2930- 6460) 
(3200- 6570) 
(6070-17750) 
(6200-11730) 
(8170-242 30) 
(6310-16270) 
(1130- 9270) 
( 23-12510) 
(1650- 6030) 
Combination 07-16: 
10-11: 
Lo/mg 
1 limits) 
6040 
1490 
4390 
8400 
12560 
9550 
4580 
3 700 
5650 
3830 
(4610-
( 130-
(3050-
(6630-
(8170-
(6310-
(1180-
(1620-
(4940-
(1480-
8250) 
3120) 
6560) 
11100) 
24230) 
16270) 
9270) 
6040) 
6480) 
6920) 
λ 
0.33 
0.40 
0.18 
0.35 
0.43 
0.40 
0.21 
0.21 
0.22 
0.17 
0.23 
0.24 
0.41 
0.40 
0.24 
1) OAAD: Ovarian ascorbic acid depletion test 
2) NM 07 - NM 16: acetone-dried glands; NM 10 - NM 11· frozen glands 
i n t e r n a t i o n a l l y accepted s tandard . The 26th WHO expert comrnittee has 
s t 
e s t a b l i s h e d the p r e p a r a t i o n known as MRC 69/104 as t h e 1 IRP for use m 
bioassay both for LH and FSH, with an assigned potency of 25 IU LH per 
ampoule and 10 IU FSH per ampoule (WtiO ECBS 26th report, 197S) . As l o c a l 
s tandard for LH the p r e p a r a t i o n NM 07 type I I was used and for FSH a batch 
of crude human p i t u i t a r y m a t e r i a l coded HHS. The r e s u l t s of the bioassays 
were s t a t i s t i c a l l y evaluated using a computer programme based on the 
" p a r a l l e l l i n e " method described by Browntee (1960). The r e s u l t s of 
repeated t e s t s of a p a r t i c u l a r assay were combined using a computer p r o ­
gramme based on a method by Finney (1964). Both computer programmes were 
kindly made a v a i l a b l e by Dr. W. Bridson (National I n s t i t u t e of Heal th, 
Bethesda, U.S.A.). 
5 . 4 . R e s u l t s and d i s c u s s i o n 
FSH. When as sayed i n t h e AOW-test a l l LH p r e p a r a t i o n s had an 
FSH a c t i v i t y of l e s s t h a n 10 IU 1 s t IRP LH/FSH bio/mg. 
LH. Table 5 - 1 shows t h e r e s u l t s of t h e OAAD-tests. The 
v a l u e s f o r t h e i n d e x of p r e c i s i o n , λ, v a r i e d between 0.2 and 
0 . 4 , which c o r r e s p o n d s t o t h e f i g u r e s r e p o r t e d in t h e 
l i t e r a t u r e (Koed & Hamburger, 1968; Schmdt-Elmendorff & 
Ьоггагпе, 1962) . The r e s u l t s for t h e LH and LH p r e p a r a t i o n s 
show a c o n s i d e r a b l e b a t c h t o b a t c h v a r i a t i o n . For some b a t c h e s 
LHT has a g r e a t e r p o t e n c y , f o r o t h e r s LHT T i s more p o t e n t . 
When t h e r e s u l t s of a l l b a t c h e s from a c e t o n e - d r i e d g l a n d s 
(NM 07, 0 8 , 09, 14, 15 and 16) a r e combined, t h e LH 
p r e p a r a t i o n s a p p e a r t o be more p o t e n t t h a n t h e LHT T 
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Table 5 - II. Potencies of human LH and LHTT determined by in VÌVO bioassay (SVW) 
Batch2' 
NM 07 
08 
09 
14 
15 
16 
10 
11 
LHI 
iu 1st 
(mean; 
12900 
5710 
3860 
3700 
2690 
4520 
1490 
IRP LH/FSH bio/mg 
95% fiducial 
(7790-18630) 
(3180-11620) 
¡2500- 6050) 
(1560- 5790) 
(1760-33790) 
(2980- 7790) 
( 910- 2780) 
limits) 
λ 
0.17 
0.30 
0.24 
0.21 
0.41 
0.20 
0.32 
I.D. 
(OAAD/SVW) 
1.1 
1.4 
1.2 
2.5 
1.1 
1.1 
2.0 
L HII 
IU lStIRP ІЛІ/FSH 
(mean 
3330 
690 
3110 
2360 
1090 
2570 
2070 
1770 
bio/mg 
; 95% fiducial 
(2450-5120) 
( 400-1120) 
(2050-5100) 
(1560-3210) 
( 2 70-2000) 
(1090-3980) 
(1060-3570) 
( 760-3010) 
1imits) 
λ 
0.20 
0.27 
0.23 
0.17 
0.25 
0.18 
0.31 
0.80 
I.D. 
OAAD/SVW) 
1.8 
2.2 
1.4 
3.5 
11 .5 
3.7 
2.2 
4.6 
Conbination 
07 - 16: 5660 (3220-11040) 2210 (1280-4120) 
10 - 11: 2580 (1340- 5810) 1920 ( 630-4560) 
1) SVW: Seminal vesicle weight test 
2) NM 07 - NM 16: acetone-dried glands; NM 10 - NM 11: frozen glands 
preparations, but there is some overlap of the 95% fiducial 
limits. Similarly, combination of the results of the batches 
NM 10 and 11 (from frozen glands) show that in these 
preparations there is no statistically significant differenre 
between the potencies of LH- and LH-.-. 
Since the introduction of the OAAD-test by Parlow there 
have appeared many reports pro and contra this method, in 
particular by those who question the specificity. Indeed, it 
has been shown that other substances also could produce an 
ascorbic acid depleting effect e.g. vasopressin (MoCann & 
Taleisnik, 1960) and serum from hypophysectomised rats 
(De Grootj 1967). Although these effects certainly must be 
taken into account when the measurement of LH in body fluids 
is considered and even constitute an impediment for the use 
of the OAAD-test for this purpose, it does not mean that the 
OAAD-test is unfit to measure LH in highly purified 
preparations. 
It should be realised that, as pointed out before, the 
OAAD-test is an acute assay. It may, therefore, be measuring 
a hormone component different from a component active in a 
chronic assay. For this reason it seemed of interest to assay 
the LH preparations also in a chronic test. The SVW-test was 
chosen, since it is much easier to perform than the classical 
VPW-test and Diazfalusy S Lorraine (19SS) had shown that the 
two tests compare favourably. The results are compiled in 
Table 5 - II. For some unknown reason, the slopes of the dose-
response curves were very flat, resulting in rather high 
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values of λ as compared to those reported in literature. This 
discrepancy may be related to the strain of animals used. 
These results of the SVW-test confirm the differences in 
potencies of LH and LH preparations, as revealed by the 
OAAD-test. The two methods may be compared by calculating for 
each preparation the index of discrimination (I.D.) i.e. the 
ratio of the potencies found in OAAD and SVW. The I.D.-values 
are presented in Table 5 - II. For the LH preparations these 
values appear to be higher than for the LH- preparations. This 
phenomenon could be explained as follows. The sialic acid 
content of the LH preparations was found to be lower than 
that of the LH- preparations (Table 3 - I). In the glyco­
proteins, sialic acid shields the galactose residue, which 
forms the point of attack for catabolism by the liver. As was 
shown for hCG (Van Hall, Vaitukaitis, Ross, Нгактап & Ashwell, 
1971) removal of the sialic acid shortens the metabolic half-
life; consequently, the potency is decreased more in chronic 
assays than in acute assays. Though applicable for the 
preparations from acetone-dried glands, this reasoning does 
not hold quite for the preparations from frozen glands (NM io­
li) because here no differences in sialic acid could be shown 
to exist between the LH and LH preparations. 
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CHAPTER 6. IN VITRO BIOLOGICAL ACTIVITY 
6.1. Introduction 
The major drawback of in vivo bioassays is their relative in-
sensitivity. During the last decade there has been a search 
for more sensitive bioassays, using as a starting point the 
physiological chain of events' initiated when the hormone 
reaches its target organ. This chain usually ends with the 
production of one or several compounds, in the case of LH e.g. 
steroids. An in vitro bioassay is an assay based on the pro-
duction of such compounds by the isolated target organ after 
incubation with the effective hormone. Instead of the whole 
organ, also tissue slices or cell suspensions can be used. It 
is self-evident that a proper in vitro bioassay can be per-
formed only if the production of the compound is quantitative-
ly related to the graded doses of the hormone. Advantages of 
in vitro bioassays as compared to in vivo bioassays are: an 
increase in sensitivity combined with a reduced variability 
and the absence of possible disturbing metabolic effects. In 
addition to its usefulness for quantitative determinations, 
target organ material can also be used to elucidate the 
mechanism of action of the hormone. From numerous investi-
gations it may be concluded that the above-mentioned chain of 
events for most hormones is as follows: the hormone binds to 
certain specific sites on the membrane of the target cells; 
the membrane-bound enzyme adenylcyclase is activated and 
catalyses the formation of cyclic AMP (cAMP) from ATP; cAMP 
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activates protein kinases which, in turn, activate phosphoryl-
ating enzymes, which, then, catalyse the formation of a final 
product. Since cAMP in most cases mimicks the action of the 
protein hormone it is called "the second messenger". For 
recent reviews see Sutherland, 1971; Major & Kilvabriak, 1972; 
Marsh, 1975. 
For the gonadotropins LH and FSH the obvious target 
organs are the gonads. For in vitro bioassay the use of 
material from the ovary as well as from the testis has been 
reported. Usually, these bioassays are based on the production 
of steroids but also other activities may be determined, e.g. 
lactate production, amino acid uptake and uridine incor-
poration (Armstrong, 196 3; JarZstedt, Hitsscn, Hamberger á 
Ähren, 197ä; Herlitz3 Hamberger S Akren, 1976; 'lilsson S 
Selstam, 1976). Although FSH is required for physiological 
events such as follicle growth or spermatogenesis, it is 
difficult to quantify these processes. Hence, the development 
of an in vitro bioassay for FSH is hampered. LH has been 
shown to regulate steroidogenesis, e.g. testosterone pro-
duction by the Leydig cells and progesterone production by the 
luteinized granulosa cells. Assay systems for LH based upon 
the dose-dependent steroidogenesis have been successfully 
employed (Watson, 1971; Dufau, Catt & Tsuruhara, 1972; 
Van Damne, Robertson & Diczfalusy, 1974) . Since LH also in-
creases the concentration of cAMP in a dose-dependent fashion, 
it is possible to take cAMP determination as an alternative 
end-point for the in vitro bioassay of LH (see review by 
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Marsh, 19 7b). Thus, the bioassay of LH consists of incubating 
a series of samples of the target tissue with increasing doses 
of LH and subsequent determination of the steroid or cAMP 
produced by means of radioimmunoassay or the technique of 
competitive protein binding. By plotting the amount of product 
versus the log dose of LH a standard curve is obtained. Con-" 
cerning the reliability of this type of assay the same 
criteria apply as outlined in chapter 4. The hormone speci-
ficity is assured as long as steroid production is taken as 
an end-point. However, in the case of cAMP determination it 
must be kept in mind that this compound is involved in nearly 
all protein-hormone induced processes. Therefore, cAMP 
determination may be used provided the hormone preparation is 
highly purified. Alternatively, if contamination with other 
hormones is suspected, a highly specific target tissue must 
be employed. 
6.2. In vitro bioassays used in this investigation 
6.2.1. Progesterone and cAMP in porcine granulosa cells 
Minimal intra-assay variation requires homogeneity of the 
target tissue. Cell suspensions are, therefore, to be pre-
ferred over tissue slices. However, dispersion of cells from 
testis or luteal tissues - structures commonly used to assay 
LH - necessitates firm treatment with enzymes like trypsin or 
collagenase which may well damage the cells. Since 
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С Р . Charming and her collaborators had shown that granulosa 
cell suspensions respond to LH with the production of cAMP 
and progesterone (see review by Charming & Tsafririj Ί977), it 
was decided to develop an in vitro bioassay for LH, using such 
granulosa cells. Suspensions of granulosa cells are readily 
prepared without enzyme treatment. Pig ovaries were used as 
a source as these organs are easily available from the 
slaughterhouse. 
6.2.1.1. Preparation of cell suspensions 
Suspension of porcine granulosa cells was carried out as described by 
Channing & Lecfoitz-Rigby (197b). Ovaries from inmature pigs, 4 - 6 months 
old, were collected at the slaughterhouse within one hour after killing of 
the animals, and kept on ice during transfer to the laboratory. Cells from 
medium-sized follicles ( 3 - 5 mm) were harvested by aspiration with a 
20 - 23 gauge, 1 inch needle connected to a water pump applying very 
gentle suction. Tne cells were separated from the follicular fluid by 
centrifugation, 5 min. at 600 g. The pellet was resuspended in Krebs 
Ringer bicarbonate buffer pH 7.4, containing 0.2% glucose and 0.1% BSA 
(KRBGA buffer). The cells were washed twice in this buffer and resuspended 
m a volume of 2 ml. After counting the number of cells in an aliquot of 
this suspension using a haemocytometer, the final volume of the suspension 
was adjusted to a concentration of 1 χ 10 6 cells per 50 ul-
6.2.1.2. Assay procedure 
The incubation mixture, pipetted in disposable round-bottommed glass tubes 
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(6 χ 50 ram) consisted of 50 μΐ of cell suspension and 450 μΐ of KRBGA 
buffer containing 1 - 1000 ng of an LH preparation (standard or unknown). 
A few incubation mixtures without LH served as controls. Incubation was 
carried out at 37 С under a 95% О + 5% CO atmosphere during 1 h if cAMP 
was to be measured, or during 20 h if progesterone was taken as an end-
point. At the end of the incubation period the tubes were centjrifuged and 
the cell pellet (for cAMP determination) or the supernatant (for 
progesterone measurement) was saved. 
6.2.1.3. Determination or cAMP and progesterone 
To prevent enzymatic degradation of the cAMP by phosphodiesterase, the 
cell pellet was resuspended in 500 μΐ of 50 mM Na-acetate pH 4.0 and the 
tubes placed in boiling water for 3 minutes. The cells were homogenized 
by hand. The horaogenate was centrifuged, 5 min. at 2000 g, and an aliquot 
of the supernatant was used for the cAMP assay (of. Lampvecht, Zov, 
Tsafriri, & Linâner·, 1973). The cAMP was measured by a competitive protein 
binding assay using the method of Gilman (1970) that was modified at three 
points: (1) bovine kidney instead of bovine muscle was used as source for 
the binding protein; (2) in the isolation procedure of the binding protein 
chromatography on DEAE-cellulose was omitted; (3) no protein kinase 
inhibitor was used. 
Progesterone was measured by a specific radioimmunoassay, described by 
Thomas, Corbey S Rolland (1977), in an n-hexane extract of the incubation 
medium. 
6.2.1.4. Results and discussion 
In the preliminary investigations an LH-- preparation (NM 14) 
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was used. Although in all experiments LH caused a rise ir pro­
gesterone levels in the medium it appeared to be impossible to 
obtain a dose-response correlation. (Recent experiments by 
Channiva (personal гоітипгсаігоги , similarly, revealed that LH 
promoted progesterone secretion but that the effect was not 
dose-dependent). The same experiments, however, revealed that 
LH invoked an increase m the level of cAMP in a dose-
dependent way. It is difficult to explain these findings. 
Channirg (1970) has shown that porcine granulosa cells from 
medium-sized follicles do not spontaneously luteinize in 
culture, but only after stimulation by LH. Our finding of 
cAMP stimulation one hour after adding LH is in agreement with 
the current concept that cAMP is indispensable for the 
initiation of the luteinization proces fChannt'ng & Seynouv, 
1970; Kolena & Charming, 1972; rhanning, 1974). Since under 
the conditions of this experiment it takes at least 12 - 16 
hours for complete luteinization of granulosa cells, it must 
be assumed that an equal period of time must elapse before 
progesterone secretion attains its maximum. Analysis of the 
progesterone production in time suggests that the cells are 
still active 10 - 12 hours after commencing incubation. 
However, the possibility of death or "dysfunction" of part of 
the cells cannot be excluded. 
The foregoing experiments were carried out during the 
summer months. Unfortunately, continuation of the experiments 
from the end of August till October yielded completely 
negative results: neither progesterone nor cAMP production 
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could be enhanced by LH. Whether t h i s must be a t t r i b u t e d t o 
s e a s o n a l v a r i a t i o n ( c o n c e r n i n g t e m p e r a t u r e , l i g h t , food, 
t r e a t m e n t of t h e animals e t c . ) of t o some o t h e r f a c t o r could 
n o t be e s t a b l i s h e d . 
This u n s a t i s f a c t o r y s i t u a t i o n prompted us t o i n v e s t i g a t e 
w h e t h e r a m o d i f i c a t i o n of t h e same assay would y i e l d b e t t e r 
r e s u l t s . 
6 . 2 . 2 . P r o g e s t e r o n e and cAMP in intact p o r c i n e f o l l i c l e s 
S t u d i e s r e p o r t e d by L i n d n e r ' s group show t h a t i n c u b a t e d i n t a c t 
r a t G r a a f i a n f o l l i c l e s respond t o LH w i t h cAMP and p r o g e s ­
t e r o n e p r o d u c t i o n (Lindner, Tsafriri, ЫеЬегтап
л
 Ζοτ, Koch, 
Bauminger & Barnea, 1974). The advantage of d i s s e c t i n g t h e 
whole f o l l i c l e i s t h a t t h e f o l l i c u l a r s t r u c t u r e remains i n t a c t 
and t h a t i n d i v i d u a l c e l l s a r e n o t damaged. The d i s a d v a n t a g e , 
however, i s t h a t t h e p o p u l a t i o n i s l e s s homogeneous t h a n a 
c e l l s u s p e n s i o n . In s p i t e of t h i s l a s t o b j e c t i o n , which c o u n t s 
h e a v i l y i n a q u a n t i t a t i v e d e t e r m i n a t i o n , t h e f e a s i b i l i t y of 
u s i n g i n t a c t p o r c i n e f o l l i c l e s of medium s i z e was i n v e s t i g a t e d . 
6 . 2 . 2 . 1 . Tissue p r e p a r a t i o n 
Ovaries from immature pigs were c o l l e c t e d as described in sec t ion 6 . 2 . 1 . 1 . 
I n t a c t , medium-sized f o l l i c l e s ( 3 - 5 mm) were care fu l ly d i s s e c t e d o u t . 
They were r i n s e d twice in Krebs Ringer b icarbonate buffer pH 7.4, con­
t a i n i n g 0.2% glucose and 0.1% BSA (KRBGA b u f f e r ) . 
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6.2.2.2. Assay procedure 
The incubation mixture, pipetted in disposable round-bottommed glass tubes 
(6 χ 50 nun) consisted of 500 μΐ KRBGA buffer containing 50 - 500 ng of an 
LH preparation (standard or unknown). A few incubation mixtures without 
LH served as controls. The follicles were divided at random over the tubes, 
one follicle per tube. On the basis of the results of a series of pilot 
studies, in which an LH preparation (NM 14) was used, incubation was 
carried out at 37 С under a 95% О + 5% ССЦ atmosphere during 1 h if cAMP 
was to be measured, or during 4 h if progesterone was taken as an end-
point. At the end of tne incjbation period the medium was removed by 
aspiration and the follicles were saved for cAMP or progesterone deter­
mination. 
6.2.2.3. Determination of cAMP and progesterone 
The follicles serving οΑίΊΡ determination were treated as follows. To 
prevent enzymatic degradation of cAMP by phosphodiesterase, 500 μΐ 50 mM 
Na-acetate pH 4.0 Was added to the tubes containing the follicles. These 
tubes were then immersed in boiling water for 3 minutes. Fragmentation of 
the follicles was ensured by squeezing and scraping with a glass rod. 
After centnfugation (5 min. at 2000 g) a portion of the supernatant was 
used for the cAMP assay as described in section 6.2.1.3. 
To the follicles to be used for progpsterone measurement, 500 yl of dis­
tilled water was added. The follicles were then fragmented as described 
above. The contents of each tube were extracted with n-hexane and the 
progesterone determination carried out according to Thomas et at (1977). 
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6.2.2.4. Results and discussion 
It may be unusual to measure progesterone in the follicular 
fluid rather than in the incubation medium. However, com-
parative pilot studies showed that the LH-induced rise in 
progesterone secretion was the same in these two compartments. 
As the radioimmunoassays of progesterone seemed to be less 
subject to aspecific effects in the case of the follicular 
fluid, analysis of this last compartment was preferred. 
Another important result is that the incubation time optimal 
for progesterone determination appeared to be 4 h, which is 
much shorter than when granulosa cell suspensions were used 
(20 h). The faster response to LH by intact follicles, as 
compared to that by granulosa cell suspension^,is probably 
related to the presence of the theca cells. Theca cells of 
immature follicles, unlike granulosa cells, are capable of 
steroidogenesis (Guvaya, 1971; Younglai, 1972; Weiss, Seamark, 
Molntosh <& Moorj 1976). They are, moreover, in direct contact 
with the LH-containing medium. The important role of the 
theca was confirmed in an experiment whereby the response of 
intact follicles was compared with that of punctured follicles 
from which the granulosa cells had been removed by scraping 
the follicular wall. (For details on this latter technique 
see Charming S Ledwits-Rigby, 1975.) There was hardly a 
difference between the progesterone production in the two 
groups. 
Unfortunately, the over-all results indicated that the 
progesterone production by intact follicles was not quanti-
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1) NM 07 - NM 16: acetono-dried glands; NM 10 - NM 11: frozen діапсіч 
tatively related to the dose of LH. The progesterone deter­
mination was, therefore, unfit as an end-point for the in 
vitro bioassay of LH and consequently it was rejected. On the 
other hand, for the LH effect on cAMP a dose-response relation­
ship was shown to exist. It has been reported that not only LH 
but also FSH stimulates cAMP production by intact rat follicles 
(Lindner et al, 1974; Lieberman, Ватба^ Bauminger
л
 Tsafriri, 
Collins & Lindner, 1975). In view of the very low FSH content 
of our LH preparations, as was established by in vivo bioassay 
(chapter 5) , any FSH-induced cAMP production was considered in­
significant. As local standard NM 14 was chosen. This 
st 
preparation, calibrated against the 1 IRP LH/FSH bio (former­
ly known as MRC 69/104), had a potency of 3840 lU/mg. The LH 
potency for all preparations are compiled in Table 6 - 1 . 
From these results, unfortunately, it must be concluded that 
the precision for this assay system is very low, reflected in 
the 'high value of λ. (Assays with a λ-value of more than 0.4 
are usually disregarded.) The reason is probably that the 
variation in maturity of the follicles is too large. Channing 
& Ledwitz-lìigby (197SÌ have shown that the LH-induced effect 
on cAMP undergoes a ten-fold increase when a medium-sized 
follicle passes into a large follicle. Although the follicles 
were carefully selected for uniform size when dissecting them, 
the boundary between "immature" and "mature" follicles is 
difficult to assess. Moreover, although only "immature" pigs 
were used, slaughterhouse material is by itself more hetero-
geneous than material from inbred animal strains. This point 
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was s t r e s s e d by the f i n d i n g of l a r g e f l u c t u a t i o n s in t h e serum 
LH l e v e l of t h e immature s l a u g h t e r h o u s e p i g s . One would ex -
p e c t t o f ind LH t o be h a r d l y d e t e c t a b l e in t h e s e an imals b u t 
l e v e l s c o r r e s p o n d i n g t o t h e l a t e f o l l i c u l a r phase of t h e n o r -
mal o v u l a t o r y c y c l e were f r e q u e n t l y found. 
By comparison of t he f i g u r e s in Table 6 - 1 t h e LH 
p r e p a r a t i o n s seem t o be more p o t e n t than the LH p r e p a r a t i o n s 
both from a c e t o n e - d r i e d g lands and from f rozen g l a n d s . 
However, in view of t h e low p r e c i s i o n of t h i s method t h e s e 
d i f f e r e n c e s cannot be r ega rded as s i g n i f i c a n t . 
1) Assays of these samples with a RIA-system for pLH were kindly carried 
out by Dr. D.F.M. van der Wiel, "Scnoonoord" Research Inst i tute for 
Animal Husbandry (I.V.O.), Zeist, the Netherlands. 
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CHAPTER 7. IMMUNOLOGICAL ACTIVITY 
7.1. Introduction 
7.1.1. Principles 
The radioimmunoassay (RIA) developed by Yalow & Berson (1960, 
196 8) and Ekins (1960; Ekins, Newman & O'Riordan, 196 8} is 
based upon competition of radio-isotope-labelled (H ] and un-
labelled hormone (H) for binding sites at the hormone's 
specific antibody (Ab). After some time the following equi-
librium exists: 
H*
 Ä H Ab 
Ab ^ 
^ ^ HAb 
The equilibrium lies far to the right. At equilibrium, H is 
either present as free hormone (F) or antibody-bound hormone 
(B). When the concentrations of H and Ab are kept constant, 
an increase in the concentration of H (QO) in the reaction 
mixture results in a diminished number of antibody binding 
ν 
sites available for H , hence В will decrease and F will in­
crease. Bound and free labelled hormone can be separated and 
the radioactivity measured. A standard curve can be constructed 
by plotting e.g. B/F as a function of QlJ. Similarly the values 
of В and F for a sample containing an unknown amount of H can 
be determined and LHD ^11 t h e sample can then be computed from 
the standard curve. Underlying the radioimmunoassay is the 
assumption that the behaviour of standard and unknown 
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preparations in their competition with the labelled hormone 
for the antibody bindirg sites is identical. 
7.1.2. Analysis of results 
There are several ways of e.valuatmg the counting results and 
constructing the standard curve. When both В and F have been 
determined the ratio B/F can be plotted against the concen­
tration of unlabelled hormone (ПО)· When either В or F has 
been counted and the initial total radioactivity of labelled 
hormone (T) is known, B/T or F/T as a percentage can be cal­
culated and plotted against £HJ. In all cases a hyperbola is 
the result. Because precise interpolation, necessary for the 
computation of the values for test samples, is troublesome 
in case of a non-linear standard curve, mathematical transfor-
mations have been applied. By plotting Гні on a logarithmic 
scale a sigmoidal curve is obtained, which shows a linear 
part. However, often this linear part is small, resulting m 
a small working range, ••odbard S Tenald (1370) suggested a 
logit/log transformation to straighten the whole line.fLogit A 
is given by In ._
д
 ). Logit B/B , where В is the fraction 
bound labelled hormone and В is the value of В when no un­
labelled hormone is present, plotted versus log {VlJ usually 
yields a straight line. 
Concerning specificity of the radioimmunoassay the 
following must be observed. A protein hormone radioimmunoassay 
would only be 100% specific if the antibodies present would 
only recognize and react with intact molecules of the hormone 
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concerned. In practice this situation will never exist: any 
antiserum contains several populations of antibodies which 
react with contaminants of the hormone preparations; also, 
parts of the hormone molecules, containing pertinent antigenic 
determinants may have been split off, and will be determined 
as if they were intact molecules. The four glycoproteins, LH, 
FSH, TSH and hCG, present yet an additional problem because of 
their structural similarity within one species, especially with 
regard to their a-subunits. Antisera against a preparation of 
one of them will include antibodies directed against antigenic 
determinants situated on the α-chain. These antibodies will 
recognize also the a-subunit of each of the other three, 
causing aspecificity of the system. It has been possible to 
partly overcome this problem by developing systems based upon 
the so-called hormone specific subunit, i.e. the 3-subunit. 
Such a system employs an antiserum raised against a purified 
g-subunit-preparation, a g-subunit-tracer, but a standard 
which may be an intact hormone preparation. In this type of 
system cross-reaction of any of the other glycoprotein 
hormones is minimal. 
7.2. Procedure for the radioimmunoassays used in this 
investigation 
7.2.1. Preparation of labelled hormone 
Peptide hormones usually are labelled by incorporation of 
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r a d i o a c t i v e i o d i n e ( I ) . The i o d i d e i s a c t i v a t e d by 
o x i d a t i o n a n d s u b s t i t u t e d i r t h e a r o m a t i c r i n g of t y r o s i n e o r 
h i s t i d m e r e s i d u e s of t h e p e p t i d e . The p e p t i d e i t s e l f may b e 
damaged by p a r t i a l o x i d a t i o n of c e r t a i n g r o u p s , e s p e c i a l l y 
s u l p h y d r y l g r o u p s . T h i s c a n b e d i m i n i s h e d by k e e p i n g t h e 
r e a c t i o n t i m e a s s h o r t a s p o s s i b l e . B e s i d e s t h e l o d m a t i o n 
damage t h e r e w i l l b e damage by r a d i a t i o n e x e r t e d by t h e i n ­
c o r p o r a t e d i o d i n e , e . g . a l t e r a t i o n of t h e p e p t i d e s t r u c t u r e . 
T h e r e f o r e , t h e l a b e l l e d h o r m o n e u s u a l l y i s s u b j e c t e d t o a 
f i n a l p u r i f i c a t i o n s t e p p r i o r t o u s e i n an a s s a y . 
All chemicals were reagent grade purchased mainly from Merck (Darmstadt, 
125 Germany). All hormones were l a b e l l e d by incorporat ion of I tIMS-3, 
Amersham, U.K.), b a s i c a l l y according t o the method of Hunter S Greenwood 
(196?). With t h e tube method described by Brown S ЕегЬк (196/) 5 yg 
hormone, dissolved in 20 μΐ 0.5 phosphate pH 7.4, 5 yg chloramine-T, 
dissolved in 5 μΐ 0.05 M phosphate рЧ 7.4 and 5 yl 0.5 M pnosptate pH 7.4 
125 
were t r a n s f e r r e d i n t o a g lass tube containing 0.5 mCi Na I in 5 yl 
NaOH-solution pH 8 - 11. The contents of the tube were mixed on a Vortex 
during 30 s. The r e a c t i o n was terminated by adding 2 40 yg Na-metabisulphite 
in 100 yl 0.05 M phosphate pH 7.4 t o n e u t r a l i z e the excess of chloramine-T. 
To prevent adsorpt ion of the lodinated hormone t o the g la s s during the next 
s e p a r a t i o n procedure 2 mg KI in 200 yl 0.02 M pnosphate buffered s a l i n e 
pH 7.4 (PBS) containing 0.25% BSA (Povi te, Amsterdam) was added. The 
l a b e l l e d hormone was then separated from the other r e a c t a n t s on a small 
G 25 column (0.5 χ 20 cm) previously e q u i l i b r a t e d in 0.02 M PBS containing 
0.25% BSA, and s tored a t -20 C. The l a b e l l e d hormone was p u r i f i e d by 
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applying it on a Whatman С 11 cellulose column (0.5 χ 20 cm) equilibrated 
in 0.02 M PBS. Labelled LH, LH , LH. and TSH are adsorbed and, after 
α ρ 
washing the column with PBS to remove hormone fragments, are eluted with 
PBS containing 4% BSA. On the other hand, in the case of iodination of FSH 
the labelled hormone is not adsorbed and may be removed by washing with 
PBS. The following highly purified hormone preparations were used for-
labelling: 
(1) hLH and hLH - prepared by dissociation of the LH preparation MM 04, 
α ρ 
which is type II LH. The FSH content of these subunits is less than 
1.25 IU 2 n IRP hMG/mg and their TSH.content is less than 1.25 mlU 1 S IRP 
TSH imm/mg, as determined by RIA. The contamination of β in hLH is 
0.3% w/w, the contamination of a in hLH is 0.1% w/w. 
ρ 
(2) hFSH - CPDS/2, a preparation kindly donated by Dr. W.R. Butt, 
Birmingham, U.K., with a stated potency of 5200 IU 2 n IRP hMG/mg in the 
AOW (Steelman & Pohley, 1953), an LH content of 1387 IU 2 n IRP hMG/mg 
st 
measured by RIA and a TSH content of 0.3 IU 1 IRP TSH imm/mg. 
(3) hTSH - NPA/2, immunochemical grade, a preparation kindly donated by 
the Hormone distribution officer, N.I.H., Bethesda, Md, U.S.A. 
7 . 2 . 2 . P r e p a r a t i o n of a n t i s e r a 
Most p e p t i d e hormones a r e s u f f i c i e n t l y immunogenic i n s e v e r a l 
animal s p e c i e s , e . g . r a b b i t , gu inea p i g , s h e e p , g o a t e t c . The 
immunogenici ty can be enhanced by a d m i n i s t e r i n g t h e hormone 
as an emuls ion mixed w i t h F r e u n d ' s a d j u v a n t . At r e g u l a r i n t e r ­
v a l s t h e a n t i b o d y t i t e r i s d e t e r m i n e d . At a s u i t a b l e t ime t h e 
animal i s b l e d and i t s serum c o l l e c t e d . 
1 ) NM 04 was prepared by Closset and had properties similar to the LH 
p r e p a r a t i o n described by Closset^ Van Dalem, Hermen & Leqwin (1975). 
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New Zealand wnite raboits wore5 a^ed for the production of antisara as 
follows: Fifty _g of hor-icne was dissolved _n 1 ml salme anc emulsified 
with 1 irl complete Freund's adjuvant. T^e emulsion was injected intra-
acrmally divided over 20 spots on tne back '"Oo-j \'i, "• ^'i'"* 3 ^(^iiir, 
1971). Once every two weeks during two montns and orco a week taereafter 
olood samples were obtained and tic antibody titer dctormned. Ше-і che 
titer was at its maximum (after approx. 1 3 - 1 6 weeks), the 3τΐΈ3ΐ was 
oled, the serum collected and scored at -70 C. Ihus, the following artisera 
were prepared: 
- code 9901 against nLH , preparation N4 0708 , 
- code 8079 agairst iLI , preparation KM 01; 
- code 8082 against nLH , a preparation described in section 7.2.1.; 
- code 8095 against hLH , a propatation described in section 7.2.1.; 
ρ 
- code 8071 against pTSH, a preparation •ondly donated by Dr. G. Honnei, 
Liège, Belgium. 
In addition the following antisera were used- anti-FSH # 3 obtained fron 
N.I.H., and anti-FSH "Pip", kindly donated oy Dr. W.R.Butt, Birmingham, 
United K_ngdom. 
7 . 2 . 3 . S tandard p r e p a r a t i o n s 
As was mentioned b e f o r e , i t ι ε e s s e n t i a l t h a t s t a n d a r d and t e s t 
p r e p a r a t i o n s a r e inmunochcmical ly i d e n t i c a l . This r e q u i r e m e n t 
i s b e s t f u l f i l l e d when b o t h p r e p a r a t i o n s a r c o b t a i n e d f ron con-
p a r a b l e s o u r c e s e . g . b o t h from p i t u i t a r y e x t r a c t s , o r b o t h from 
u r i n e e t c . To be a b l e t o compare o n e ' s own r e s u l t s wi th t h o s e 
of o t h e r i n v e s t i g a t o r s t h e use of i n t e r n a t i o n a l l y a c c e p t e d 
s t a n d a r d p r e p a r a t i o n s i s o b l i g a t o r y . Such p r e p a r a t i o n s a r c 
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c h a r a c t e r i z e d by s e v e r a l c r i t e r i a , e . g . b i o l o g i c a l a c t i c i t y , 
p h y s i c o - c h e m i c a l p r o p e r t i e s , s t a b i l i t y e t c . As t h e y a r e o f t e n 
a v a i l a b l e i n o n l y l i m i t e d a m o u n t s , i t i s c u s t o m a r y t o u s e a 
l o c a l s t a n d a r d w h i c h h a s b e e n c a l i b r a t e d a g a i n s t t h e i n t e r ­
n a t i o n a l s t a n d a r d . 
LH: Local s tandard - NM 01, prepared and described by Closset et al (19/6). 
s t The potency of t h i s p r e p a r a t i o n i s 2256 IU 1 IRP LH imm/mg in the 
s t 
s tandard assay. All r e s u l t s are expressed in terms of the 1 IRP for 
immunoassay, formerly known as MRC 68/40 with an assigned potency of 
77 IU/ampoule (approx. 6640 lU/mg) (WHO - I CBS P6th Report, 1975). 
FSH: Local s tandard - CPDS/6, a p r e p a r a t i o n kindly donated by Dr. W.R.Butt, 
Birmingham, U.K., with a s t a t e d potency of 5600 IU 2 IRP hMG/mg m the 
AOW and an LH content of 119 IU 1 IHP LH imm/mg; TSH content not known. 
All r e s u l t s are expressed in terms of the 2 IRP hMG with an assigned 
potency of 40 IU/ampoule (approx. 9 lU/mg) (r/HO - FOBS 15th Rpport, 1964). 
TSH: No l o c a l s tandard was used. All r e s u l t s are expressed in terms of t h e 
s t 1 IRP TSH for immunoassay, formerly known as MRC 68/38 with an assigned 
potency of 0.15 lu/ampoule (approx. 3.2 lU/mg) (M0 - "CBS 26th Report, 
1975). 
7.2.4. Separation of bound and free hormone fractions 
Many procedures are available, the choice depending on whether 
both the bound and free labelled hormone are to be measured or 
only one of them. The most common methods comprise precipit­
ation of fraction В by polyethyleneglycol or ammonium 
sulphate, immunological precipitation of В by a second anti-
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body, or adsorption of F t o dextran-coated charcoal . For ex­
tended surveys the reader i s referred t o Yalow <S Berson (19 73) 
and Rat ali fJe (197 4). 
Our separa t ion was obtained by immunological p r e c i p i t a t i o n of the bound 
f r a c t i o n with a sheep a n t i - r a b b i t γ-g lobul in coupled t o c e l l u l o s e (DASP, 
Organon). 
7.2.5. Assay procedure 
All components were dissolved in or diluted with PBS pH 7.4 containing 
1% BSA. The incubation mixture, pipetted in disposable glass tubes (Rhesus 
ampoules, Forma Vitrum, St. Gallen, Switzerland) consisted of 50 μΐ of 
labelled hormone, 50 yl of antiserum diluted as appropriate, 400 i_l of the 
PBS containing the standard or test preparation. Incubation was carried 
out either during 2 h. at 37 С (hereafter referred to as quick assays) or 
during 4 days at 4 С (hereafter referred to as standard assays). At the 
end of the incubation 1 ml of a 1:10 dilution of DASP was added to each 
tube. After mixing, the tubes were incubated for another 30 - 180 Tim. 
depending on the binding capacity of the particular batch of DASP. The 
tubes were centrifuged, 2 m m . at 2000 g, the supernatant siphoned off and 
the pellet washed twice with saine. Finally, the radioactivity in the 
pellet was counted m an LKB Waliac 80000 gammascintillation counter. The 
data were evaluated using a computer programme developed by Rodbavd & 
Lewald (1970). 
7.2.6. Quick assays 
During purification, hormones should be kept in solution as short as 
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Table 7 - 1 . Summary of various radioimmunoassay systems used for determination of 
human LH, FSH and TSH activities. 
Hormone 
LH 
LH 
LH 
FSH 
FSH 
TSH 
Labelled hormone 
preparation 
NM 04 LH, 
Ρ 
NM 04 LH 
ρ 
NM 04 LH 
α 
CPDS/2 FSH 
CPDS/2 FSH 
NPA 2 TSH 
•20000 
^ 500 
5000 
ъ 100 
5000 
я- 100 
20000 
~ 500 
5000 
'ь 100 
5000 
-v. 100 
cpm 
pg 
cpm 
pg 
cpm 
pg 
cpm 
pg 
cpm 
pg 
cpm 
pg 
Antiserum 
(final dilution) 
8095 
8095 
8082 
Pip 
NIH # 3 
8071 
1:10000 
1:100000 
1:100000 
1:10000 
1:100000 
1:25000 
Local 
standard 
preparation 
NM 01 
NM 01 
NM 01 
CPDS/6 
International 
standard 
preparation 
lStIRP 
lStIRP 
lStIRP 
2ndIRP 
2ndIRP 
lStIRP 
LH imm 
LH imm 
LH imm 
hMG 
hMG 
TSH imm 
Mode of assay 
(standard or quick) 
quick 
standard 
standard 
quick 
standard 
standard 
poss ib le for reasons of s t a b i l i t y . Monitoring the e l u t i o n p r o f i l e s of trie 
g o l f i l t r a t i o n columns 'ahjpLCF ") by s tandard RIA-proccduro would take a t 
l e a s t 4 - 7 days. Therefore, quirk assays were developed which di f fered 
froir the s tandard procedure in t h a t a la rgor amount of l a b e l l e d hormone 
was employed t o reduce the counting t ime, wnile a decreased d i l u t i o n of 
the antiserum was used and incubation done a t 37 С t o reach equi l ibr ium 
f a s t e r . In t h i s fashion the r e s u l t s were known within 2 days. 
All radioimmunoassay systems used are summarized in Table 7 - 1 . 
7 . 3 . R e s u l t s and d i s c u s s i o n 
L-'i'.Tne immunological LH a c t i v i t y of a l l p r e p a r a t i o n s was 
measured by t h e quick as w e l l as t h e s t a n d a r d LH^-system. 
Table 7 - I I shows t h e p o t e n c i e s in terms of t h e l o c a l s t a n d a r d 
s t NM 01 and t h e i n t e r n a t i o n a l s t a n d a r d 1 IRP LH imm. The index 
of p r e c i s i o n λ u s u a l l y v a r i e d between 0.02 and 0 . 0 8 , which i s 
t h e normal range m t h i s l a b o r a t o r y . As t h i s Table shows, f o r 
a l l b a t c h e s a n a l y s e d t h e LH p r e p a r a t i o n s have a lower p o t e n c y 
t h a n t h e LH p r e p a r a t i o n s both in t h e quick and in t h e 
s t a n d a r d a s s a y . There could be s e v e r a l e x p l a n a t i o n s f o r t h i s 
phenomenon: 
(1) I t was shown by Іеаліі, ùcgcvs, Cíossct & ІІСЛІСЛ {107 ^) 
t h a t in t h e s t a n d a r d LH.-system h i g h l y p u r i f i e d LHQ i s about 
10 t i m e s as p o t e n t as NM 01 (an LH p r e p a r a t i o n former ly 
c a l l e d LH/LN) on a we ight b a s i s (F ig . 7 - 1 ) . One might assume 
t h e n , t h a t f r e e LH^, p r e s e n t as c o n t a m i n a t i o n i n t h e LH 
ρ 
preparations, would affect the potency proportionally to the 
78 
Table 7 - II. Potencies of human LH and LH determined by radioimmunoassay. 
Batch1' 
NM 0 7) 
08 
09 
14 
15 
16 
10 
11 
NM 07 
08 
09 
14 
15 
16 
10 
11 
ш
і 
NM 01 lU lStIRP LH imm/mg 
(mean; 95% fiducial limits) 
Ш
І І 
NM 01 IO lStIRP LH imm/mg 
(mean; 95% fiducial limits) 
Standard system 
,1.00 (0.92-1.10) 2660 (2440-2920) 
0.43 (0.36-0.52) 1140 ( 960-1380) 
1.00 (0.95-1.17) 2660 (2520-3120) 
0.63 (0.51-0.78) 1670 (1350-2080) 
0.65 (0.52-0.79) 1730 (1380-2100) 
0.31 (0.21-0.39) 830 ( 560-1040) 
0.27 (0.20-0.36) 720 ( 530- 960) 
Combination 07-16:1900 (1670-2210) 
10-11: 810 ( 750- 890) 
1.05 (0.91-1.23) 2790 (2400-3280) 
0.73 (0.60-0.88) 1940 (1590-2340) 
1.00 (0.88-1.16) 2660 (2340-3100) 
1.42 (1.23-1.65) 3770 (3270-3480) 
1.45 (1.19-1.72) 3850 (3160-4570) 
1.12 (0.81-1.68) 2980 (2150-4460) 
0.45 (0.39-0.53) 1200 (1040-1410) 
0.96 (0.65-1.45) 2550 (1730-3850) 
Combination 07-16: 3000 (2790-3300) 
10-11: 2040 (1460-2680) 
Quick system 
;0.63 (0.56-0.78) 4180 (3720-5180) 
0.48 (0.43-0.53) 3190 (2860-3520) 
0.59 (0.53-0.65) 3920 (3520-4320) 
0.34 (0.31-0.37) 2260 (2060-2460) 
0.40 (0.38-0.42) 2660 (2520-2790) 
0.33 (0.32-0.36) 2190 (2120-2390) 
0.25 (0.23-0.27) 1660 (1530-1790) 
Combination 07-16:3240 (2910-3620) 
10-11:1930 (1700-2190) 
0.86 (0.82-0.90) 5710 (5440-5980) 
0.98 (0.93-1.01) 6510 (6180-6710) 
1.00 (0.97-1.03) 6640 (6440-6840) 
1.00 (0.96-1.03) 6640 (6370-6840) 
1.13 (1.08-1.20) 7500 (7170-7970) 
1.30 (1.24-1.36) 8630 (8230-9030) 
0.43 (0.41-0.45) 2860 (2720-2990) 
0.35 (0.33-0.37) 2320 (2190-2460) 
Combination 07-16: 6600 (6350-6880) 
10-11: 2590 (2340-2850) 
1) NM 07 - NM 16: acetone-dried glands; NM 10 - NM 11: frozen glands. 
2) NM 01 (IU l s tIRP LH ιmm/mg): 2656 (Standard system); 6640 (Quick system); see text for details. 
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d e g r e e o f c o n t a m i n a t i o n . I n F i g . 7 - 2 t h e p o t e n c i e s of t h e LH 
p r e p a r a t i o n s i n t e r m s of NM 01 h a v e b e e n p l o t t e d a g a i n s t t h e 
LH. c o n t a m i n a t i o n s t h a t w e r e r e p o r t e d i n T a b l e 3 - I I I . I t 
ρ 
appears that there is no correlation and therefore the above 
possibility must be rejected. 
(2) The LH0-systems employ antibodies raised against a 6-sub-
P 
unit preparation derived from NM 04 LH _ as well as an LHT_-B-
subunit-tracer (a so-called homologous system). It would be 
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conceivable that intact LH -molecules are less able to compete 
in this system than intact LH -molecules. Λ control experiment 
using a system based upon the (B-subunit from LH would have 
been appropriate. Unfortunately, at the time such a system was 
not available. However, the answer to the question could be 
approximated by comparison of the behaviour of LH and LH 
preparations in homologous intact LH - and intact LH -systems 
as well as cross-over experiments. The following four com­
binations were run simultaneously: 1. Anti-LH + tracer LH ; 
2. Anti-LH + tracer LH ; 3. Anti-LH + tracer LH ; 4. Anti-
LH _ + tracer LH . In all these systems the activities of an 
LH preparation (NM 0708 ) and an LH preparation (NM 01 ) 
were compared. The dose-response lines obtained are presented 
in Fig. 7 - 3;those for NM 0708 are not straight over the whole 
range probably due to cross-reacting components. The 
difference in activities of the two preparations appears to be 
the same in all four systems and is similar to that found in 
the standard LH^g-system (Table 7 - II) , i.e. NM 0708J./NM 01 
^ 0.8 - 1.0. Therefore, it would seem unlikely that the ob­
served difference in potency between LH and LH
 T is the con­
sequence of using an LHTTb-system. Since the difference in 
immunological potencies of I.H and LH T T preparations cannot be 
attributed to Tiethodological influences it must be concluded 
that the LH- preparations in immunological respect ¡just are 
slightly less purified than the ΙΉ preparations. 
Comparison of the results of quick and standard assays is 
of interest, if only for rating the value of the quick assay. 
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? t f i r s t g l a n c e a l l p r e p a r a t i o n s seem t o h a v e r o u g h l y t h e same 
p o t e n c i e s m q u i c k a n d s t a n d a r d a s s a y s , a t l e a s t when e x p r e s s e d 
i n t e r m s of t h e l o c a l s t a n d a r d NM 01 ( T a b l e 7 - I I ) . H o w e v e r , 
c o m p a r i n g t h e r e s u l t s of q u i c k and s t a n d a r d a s s a y s when t h e s e 
s t 
a r e e x p r e s s e d i n u n i t s of t h e 1 IRP LH i m m . , c o n s i d e r a b l e 
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differences in potency become apparent. I.equin et al '1974) 
have established that the potencies of highly purified LH , 
st 1 IRP LH irati, and NM Ol in a standard LH -system were in a 
ratio of 10 : 2.5 : 1 (Fig. 7 - la). As the potency of the 
st 1 IRP LH imm. has been assigned to be 6640 lU/mg, it follows 
that the potency of NM 01 in this LH -system is 6640 χ 1/2.5 
= 2656 lU/mg. The same preparations were tested in the quick 
LH -system. This time the potencies were in ratio of 4 : 1 : 1 
(Fig. 7 - lb). Since the antiserum dilution used in the quick 
system was a factor 10 less than in the standard system, this 
might have influenced the relative potencies. A control ex­
periment using the same antiserum dilution in the quick system 
that was used in the standard system, showed that the relative 
potencies remained 4 : 1 : 1 (Fig. 7 - 1c). Thus, in the quick 
st 
system the 1 IRP LH imm. and NM 01 are equipotent (6640 IL/mcJ . 
How can the difference in potency of NM 01 between quick and 
standard system be explained? It has been shown before (Lequin, 
st 1976) that the 1 IRP LH imm. contains approx. 26% ß-subunits 
(w/w), and NM 01 approx. 3%. While these preparations have been 
kept lyophilized at -20 С for several years there has been no 
change in these figures. However, recent observations in this 
laboratory indicate that, when in solution at elevated tem­
perature (37 C ) , the preparations are not stable and some dis­
sociation into subunits occurs. Since the components of the 
assay mixture are the same in quick and standard assays but 
the only difference concerns the temperature, the observed 
difference in potency could well be attributed to the tem-
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perature factor. Furthermore, theœ appears to be a slight 
negative correlation between the degree of temperature-
dependent dissociation and the anount cf s\_bunits already 
st present, since the potency of the 1 IRP LH imm. with a high 
initial content of 0-subunits does not noticeably shift with 
respect to that of pure LH whereas the potency of NM 01 with 
a low content of ß-subunits, alters drastically. From the fact 
that the potencies of the LH preparations, when measured 
against NM 01, hardly show differences between the standard 
and quick systems, it may be concluded that these preparations 
shift more or less in a manner similar to that of NM 01. 
Finally, comparison of the results of the preparations 
from frozen glands and from acetone-dried glands show that 
irrespective of system and standard, the preparations from 
frozen glands (NM 10 - 11) have a lower specific immunological 
activity, probably due to a larger content of inert protein. 
FSH and TSH.The FSH- and TSH-contaminations m the LH 
preparations were measured m the standard assay systems 
specific for these hormones. The results are presented in 
Table 7 - III. The FSH-contamination in the LH preparations 
is higher than in the LH preparations. This is not sur-
prising when it is realised that complete separation of FSH 
and LH was not possible (chapter 2). These figures for the 
FSH-contamination are in agreement with those found by in vivo 
bioassay (chapter 5). As there was no bioassay available for 
measuring ΤΞΗ activity, these figures cannot be checked, but, 
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Table 7 - III. Determination of FSH and TSH contaminations in numan LH and LH. 
by radioimmunoassay. 
Batch1' 
NM 07 
08 
09 
14 
15 
16 
10 
11 
LHI 
FSH TSH 
IU 2ndIRP/mg IU lStTRP TSH imn/mg 
(mean; 9b% fiducial limits) 
22 (17-27) 0.035 (0.033-0.037) 
20 (15-26) 0.250 (0.231-0.2/5) 
11 ( 8-14) 0.001 (0.000-0.002) 
88 (78-98) 0.039 (0.037-0.042) 
43 (35-53) 0.057 (0.052-0.062) 
56 (48-64) 0.005 (0.004-0.006) 
39 (32-46) 0.008 (0.007-0.009) 
L HII 
FSH TSH 
IU 2ndIRP/ng IU lStIRP TS4 imm/mg 
(mpan,- 951 fiducial linits) 
?4 (19-29) 0.191 (0.171-0.215) 
7 ( 6 - 9 ) 0.030 (0.024-0.0 56) 
14 (11-17) 0.04¿ (0.034-0.050) 
12 (10-14) 0.031 (0.025-0.035) 
0 ( 7-10) 0.012 (0.010-0.014) 
4 ( 3- 5) 0.022 (0.019-0.026) 
9 ( 8-11) 0.005 (0.004-0.006) 
5 ( 4 - 6 ) 0.001 (0.000-0.002) 
1) NM 07 - NM 16: acetone-dried glanas; NM 10 - NM 11: froren glands. 
if the assumption is made that the immunological activity in 
some way represents the biological activity, at least they 
form a strong indication that the LH preparations are con-
taminated only very slightly with TSH. This impression is 
strengthened when the TSH activities of these LH preparations 
st 
and a highly purified TSH preparation, e.g. the 1 IRP TSH 
imm., are compared: the difference is approximately a hundred-
fold. 
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CHAPTER 8. ACTIVITY MEASURED BY RADIOLIGAND ASSAY 
8.1. Introduction 
8.1.1. Principles 
Although during the last decade the radioimmunoassay v/as ac­
cepted as the method of choice for estimating very low con­
centrations of circulating peptide hormones, there was an in­
creasing recognition that this assay system is not only 
measuring the "active" hormone, i.e. those molecules which are 
able to elicit a physicological response from the target organ. 
Also "inactive" fragments are recognized by the antibody-
binding sites. Autoradiographic studies indicated that a 
peptide hormone is concentrated in its target organ where it 
is bound to the cell membrane (^spelo-rd, yaftolzr> & Pa ilsenj 
1968, E<ih<ol S Innerfeld, ТЭб?, 'Izdgley, 1977). С 'atreoasai 
(1969) coupled insulin to Sepharose and incubated this complex 
with isolated fat cells; the fact that the solid-phase insulin 
which could not penetrate into the cells, was able to exert 
its normal biological effects led him to the conclusion that 
it was sufficient for the hormone to be in contact with the 
plasma membrane of the cells. From studies concerning binding 
of labelled ACTH to extracts of an adrenal tumor 'e f k o j i t ? , 
Roth, Р гаег & Vastan (10/Oa,b) developed the first radio-
ligand-cell-membrane-receptor assay (RLA). This assay is based 
upon the principle of competition between labelled and un-
labelled hormone for binding sites (receptors) on the plasma 
88 
membranes of target organ cells. It is assumed that the hor-
mone-receptor complex is identical to that existent in vivo 
and that only the "biologically active" hormone molecules are 
measured. Since 1970, radioligand assay systems have been 
developed for a large number of protein and peptide hormones; 
only those for LH (or hCG) will be discussed in this chapter. 
8.1.2. Analysis of results 
Again, there is a close conformity between RLA and RIA because 
the methods for statistical evaluation of the results 
developed by Rodbard & Lewald (1970) for the RIA as well as 
the theoretical considerations about reliability (Borth, 19S7) 
are also applicable to the RLA (Rodbard, 1975). With regard to 
one of the reliability criteria namely specificity, however, 
there are some important differences. Natural receptor sites, 
unlike induced antibodies, bind the hormone concerned more 
specifically. This has been confirmed in studies investigating 
cross-reactivity of other highly purified hormone preparations. 
Further, in the case of the glycoproteins in the RLA, there is 
no interference by structurally similar subunits, because the 
subunits are completely inactive. 
8.2. Procedure for the radioligand assays used in this 
investigation 
8.2.1. Preparation of labelled hormone 
The binding of the hormone to its tissue binding sites is much 
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more susceptible to alterations in the hormone structure than 
is the binding to antibody-binding sites. This means that 
during the labelling reaction mild conditions have to be ob-
served. Because incorporation of 125-iodine involves an 
oxidative milieu, some investigators have turned their 
attention to the use of tritium. This isotope nay be incorpor-
ated by e.g. methylation or carbamylation of the protein chain 
(De la LÎOS2, Durooay, "•erlhi-Clary '3 Jwiaa, 1374; Гз Ία 
Llosa-Her^ier, Неггы'ег ί '.JC la ΐΊοεα, 1976) or by oxidation 
and reduction of the sialic acid (l'ai tukiit Ιε, Hanimond, hoss, 
Чгоктап -5 Ashhißll, 1071a; '.'тіtukaif'з, Спетгкзj, Ross, '¡гакпап 
& Ashuell, 19/lb). Besides the fact that the tertiary structure 
of the hormone is less affected by incorporation of tritium 
than by iodine, another advantage of tritium over 125-iodine 
is the longer shelf-life of the tritiated hormone, due to a 
longer decay-time and a less damaging radiation effect on the 
molecular structure. Unfortunately, however, important disad­
vantages of tritium are that it is difficult to incorporate 
and that it is a 8-emitter, which necessitates the use of 
scintillation fluid and long counting-times. Therefore, most 
investigators still choose 125-iodine as a label and modify 
the conditions of the iodination reaction to keep the damage 
as low as possible. Nowadays, the chloramine-T method (Hunter 
& Greenwood, 1961) under mild conditions as described by 
Leidenbergir & Reichert '.±?7Zb) and the enzymatic lactoper-
oxidase method developed by '',iya"hi, Chrairbach, "¡ecklenburg -3 
Lipsetl (1970) are most commonly in use, but other gentle 
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lodination procedures have been described as well (Buit, 197?). 
Since the chloramine-T method under mild conditions (Leidenbevger & 
Reiohert, 1972b) as well as the lactoperoxidase method (Miyaohi et al3 
1973) have been recommended, it was decided to compare tnese two methods 
with respect to the in vivo biological activity of the labelled products. 
The chloramine-T method was carried out as described in chapter 7 section 
7.2.1. except that the amount of chloramine-T was reduced to 2.S yg, and 
the reaction mixture was kept at 0 C. Tne lactoperoxidase method, 
modified by Van Toorenenbergen & Lequin , was used: 5 pg LH, dissolved 
in 15 yl 0.05 M phosphate pH 7.4, 1.25 yg lactoperoxidase coupled to 
Sepharose 4B (to facilitate its removal from the reaction mixture) sus­
pended in 15 yl 0.01 phosphate buffered saline pH 6.5 and 5 yl 0.4 mM H O 
125 
were pipetted into a glass tube containing 0.5 mCi I in 5 yl NaOH. 
The tube was placed m an ice bath and the contents were mixed. After 
15 minutes the reaction was terminated by adding 200 yl 0.025 M NaN + 
0.025 M KI. The labelled hormone was separated from the other reactants 
on a small G 25 column (0.5 χ 20 cm) previously equilibrated in 0.02 M 
PBS containing 0.25% BSA and stored at -20 C. The in vivo biological 
activity of the labelled hormones was determined in Parlow's OAAD-test 
(Рагіоъ)} 1961; see ohapte/· 5, section 5.6). The results of this study, 
summarized in Table 8 - 1 , indicate that both methods produced equivalent 
results, concerning the biological activity as well as the specific 
incorporated radioactivity. The chloramine-T method was chosen because 
it is the easiest to perform. For labelling the LH preparation NM 09 was 
1) Van Toorenenbergen A.W. & Lequin R.M., unpublished results. 
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used. Before uso the t r a c e r was p u n fjed as described in chapter 7 
s e c t i o n 7 . 2 . 1 . 
Table 8 - 1 . Effect of two l o d i n a t i o n methods on the b i o l o g i c a l 
a c t i v i t y (OAAD-test) of human LH 
Lactoperoxidase 
Chloramme-T 
Specific 
activity 
yCi/ug 
40 
24 
15 
?3 
34 
33 
Final biol. act. 
Initial biol. act. 
97 
51 
64 
75 
80 
190 
in % 
(48-193) 
(33- 80) 
(40-112) 
(62- 92) 
(47-150) 
(62-497) 
λ 
0.33 
0.16 
0.30 
0.20 
0.65 
0.65 
8 . 2 . 2 . P r e p a r a t i o n of b i n d i n g t i s s u e 
S i n c e b o t h t h e o v a r y a n d t h e t e s t i s a r e t a r g e t o r g a n s f o r LH, 
e i t h e r o n e may b e s e l e c t e d f o r t h e p r e p a r a t i o n of t i s s u e f r a g ­
m e n t s . M e t h o d s e m p l o y i n g t h e w h o l e o r g a n a f t e r f r a g m e n t a t i o n 
(Leidenberger & РегскегЬ, 1972а,Ъ; lee & Ryan, Ì97T, 1972; 
Tsuruhara, Van Hall, Du f ал & Cati, 1972, Koah, 7or, Chóbsieng^ 
Larpreohi, Pcmerantz & TAndt¡er, 19/4) a s w e l l a s t e c h n i q u e s 
i n v o l v i n g i s o l a t e d s p e c i f i c c e l l t y p e s (Cati, Dvfai/, Ta truhara, 
1971, 1972; KaiTnerman, Can freíd, Kolena & Channing, 19/2) h a v e 
b e e n r e p o r t e d . 
Binding t i s s u e was prepared according to Kooh et al (1974). Female Wistar 
r a t s were rendered pseudo-pregnant by pre t rea tment with PMS (50 IU) + 
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hCG (25 lu). Between 5 and 9 days after the hCG injection the animals were 
killed. The ovaries were carefully dissected out and weighed. The ovarian 
weight varied from 60 - 90 mg. The ovaries were homogenized at 0 С in a 
Krebs Ringer bicarbonate buffer pH 7.4, containing 0.1% BSA (Sigma) and 
0.2% glucose (KPBGA buffer), using an all-glass homogenizer with a loose-
fitted pestle, manually applying three strokes only. The homogenate con­
taining intact cells as well as membrane-fragments was strained through 
cheese cloth and diluted with the same buffer to contain an equivalent of 
10 mg ovarian weight per ml. 
8.2.3. Standard preparations 
E s s e n t i a l l y t h e same s t i p u l a t i o n s t h a t were s t a t e d f o r 
p r e p a r a t i o n s measured i n t h e RIA (ohapter 7 section 7.2.3.) 
must a l s o be f u l f i l l e d i n t h e RLA, i . e . i d e n t i c a l b e h a v i o u r 
of s t a n d a r d and t e s t p r e p a r a t i o n s , comparable s o u r c e s and 
c a l i b r a t i o n a g a i n s t i n t e r n a t i o n a l s t a n d a r d s . 
As l o c a l s tandard in each assay NM 14 was used. When c a l i b r a t e d aga ins t 
s t the 1 IRP for LH and FSH for b ioassay, formerly known as MRC 69/104, 
with an assigned potency of 25 IU LH/ampoule, NM 14 turned out t o have 
a potency of 21400 lU/mg.(When c a l i b r a t e d aga ins t the 2 n IRP hMG, 
NM 14 had a potency of 23000 lU/mg.) 
8.2.4. Assay procedure 
All components were dissolved in or diluted with KRBGA buffer. The 
incubation mixture, pipetted in round-bottommed disposable glass tubes 
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4-
time 30 mm 
B/j e/«) 
V 
4-
2- , 
temp 37 С 
25 37 56 — ι — 
40 Θ0 120 
— ι 
160 m m 
Fig. 8 - 1 . Determinati-on of optmal conditions for the proceduto 
of thp radioligand аьзау for Lh. 7"„."t. Influence of incubation 
temperature on binding. Open bars indicate percentage total 
binding, closed bars indicate percentage aspecific binding. ^іаЬі · 
Influence of incubation time on binding. ·—β indicates percentage 
total binding, χ—χ indicates percentage aspecific binding. 
(6 χ 50 mm), consisted of 1.0 ml of tissue homogenate, 50 yl of labelled 
hormone and 200 yl of KRDGA buffer containing standard or test preparation. 
The incubation was carried out during 1 h. at 37 C, wnich appeared to be 
the optimal condition (Fig. 8 - 1), under a 95» 0 + 5% CO atmosphere. 
Under tnese circumstances tne total binding ranged from 5 - 10" and the 
non-specific binding, defined as the binding in the presence of an infinite 
amount of unlaoelled Lri or hCG, from 0 1 - 0.5%. At the end of the in­
cubation the tubes were centnfuged 5 m m . at 2000 g, the supernatant 
siphoned off and the pellet uas counted in an LKB «Vallac 80000 gamma 
scintillation counter. To ascertain that labelled and unlabelled hormone 
behaved identically in the competition for binding sites, the following 
experiment was done. By adding increasing amounts of tracer a competition 
between the labelled molecules thenselves rfas generated, the "standard" 
curve obtained in this manner parallels the normal standard curve (Fig.8-2). 
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В/j (%) 
Fig. θ - 2. Regression l i n e s for r a d i o a c t i v e l a b e l l e d 
and unlabe l led LH in the rad io l igand assay. 
Speci f ic a c t i v i t y 1 2 5 I-NM 09 : 30 uCi/ug. 
For the c a l c u l a t i o n of the potencies of the LH p r e p a r a t i o n s the data were 
evaluated using e i t h e r a computer programme developed by Podkard & Lewald 
(1970) or a computer programme based upon the p a r a l l e l - l i n e method by 
Brownlee (1960). The r e s u l t s of severa l assays were comoined using a 
computer programme based upon a method by Finney (1964). The l a s t two 
computer programmes were kindly made a v a i l a b l e by Dr. W. Bridson ( N . I . H . , 
Bethesda, Md. U.S.A.). 
8 . 3 . R e s u l t s a n d d i s c u s s i o n 
The p o t e n c i e s of t h e LH p r e p a r a t i o n s t e s t e d i n t h e RIA a r e e x ­
p r e s s e d i n t e r m s of t h e l o c a l s t a n d a r d NM 1 4 T T a n d t h e m t e r -
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national reference preparation 1 IRP LH/FSH bio. The choice 
of this particular international reference preparation needs 
some explanation. The 26th Committee of the WHO recommended to 
make a distinction in the use of standards for bioassays and 
for immunoassays (WHO - FC*S SCih Report, 197b). Henceforth, 
it established International Reference Preparations and Inter­
national Standard especially for the purpose of bioassays, and 
others especially for the purpose of immunoassays. However, 
there is no agreement whether radioligand assays belong to the 
bioassays or to the immunoassays. On the one hand it can be 
argued that, like the RIA, the RLA measures hormone levels on 
the basis of the hormone structure rather than on the basis of 
hormone function; on the other hand it employs tissue (cells, 
membranes) of target organs and could, therefore, be considered 
st to be a bioassay. Although the 1 IRP LH/FSH bio recently was 
established for use in bioassays, this preparation (formerly 
MRC 69/104) has been prepared from LER 907, a well-known 
pituitary preparation that is still widely used as reference 
preparation for radioimmunoassay. Also in view of the decision 
s t 
of the 26th Committee to recommend the 1 IRP LH/FSH bio as a 
provisional standard for radioimmunoassay of FSH, this 
preparation was selected here for use in the RLA by lack of a 
good alternative. 
Table 8 - II shows the potencies of all LH preparations 
tested. These results show that this type of assay has a lower 
precision (reflected in a higher λ-value) than the RIA. Also, 
for some preparations (e.g. NM 0708.., NM 15TT) , repeated 
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Table 8 - II. Potencies of human LH and LH determined by radioligand assay. 
LH. LH II 
Batch 1) IU lStIHP LH/FSH bio/mg 
(mean; 95% fiducial limits) 
IU 1S IRP LH/FSH bio/mg 
(mean; 95% fiducial limits) 
40 
NM 07 
08 
09 
14 
15 
16 
10 
11 
9400 ( 7900-11300) 
6800 ( 3600- 7500) 
17500 (13500-21900) 
25900 (19500-34500) 
3400 ( 2800- 4000) 
6200 ( 4500- 8300) 
7300 ( 5100- 9200) 
1300 (11300-15200) 
0.09 
0.14 
0.16 
0.14 
5100 ( 4700- 6000) 
0.12 
0.09 
0.09 
3200 ( 2800- 3900 
3900 ( 2100- 5 
) ) 
100) J 
4700 ( 2600- 9400) 
5400 ( 2100-10300) 
9800 ( 8800-13500) 
4100 ( 3000- 4900) 
4900 ( 3600-
5600 ( 2400-
6000) 
4700) 
2800 ( 1500- 3400) 
5600 ( 4500- 6800) 
Combination 07-16: 
10-11: 
3400 ( 2600- 4300) 
4900 ( 2400- 9800) 
5400 ( 4500- 6000) 
5100 ( 4000- 6400) 
4100 ( 3600- 4700) 
6200 ( 5700- 6800) 
4800 ( 4200- 5500) 
0.10 
0.28 
0.10 
0.12 
0.09 
0.11 
0.11 
0.13 
0.08 
0.11 
13900 (10500-34200) 
19900 (17100-23800) 
11800 ( 9600-14800) 
5300 ( 2800- 9000) 
4900 ( 3900- 6400) 
8800 ( 5600-12600) 
21400 .(19000-23800) 
22000 (18800-26300) 
28000 (20100-38710) 
20100 (16300-24000) 
22000 (17500-27300) 
20800 (16800-24100) 
21200 (18000-23800) 
28900 (24800-33800) 
11300 ( 9400-13700) 
20100 (17100-23500) 
18400 (14600-21600) 
11100 ( 8300-16700) 
19300 (15400-24400) 
8100 ( 6000-10700) 
7700 ( 6000- 8800) 
15000 (13300-17100) 
6600 ( 5100- 8100) 
22300 (19900-25300) 
21400 (17600-25700) 
17100 (15200-19300) 
19000 (17100-21400) 
15200 (12600-18600) 
7900 ( 7300- 9800) 
0.11 
0.09 
0.10 
0.25 
0.13 
0.19 
0.06 
0.08 
0.15 
0.20 
0.09 
0.00 
0.09 
0.07 
0.08 
0.07 
0.12 
0.09 
0.10 
0.07 
Combination 07-16: 17400 
10-11: 12000 
(16300-19000) 
(10300-13200) 
1) NM 07 - NM 16: acetone-dried glands; NM 10 - NM 11 : frozen glands. 
potency determinations by the RIA yield rather divergent 
results. It is difficult to explain fully this last vari­
ability. Buffer, hormone solutiors and tracer were always 
prepared freshly. The only variable was the day during pseudo-
pregnancy on which the ovaries were used, i.e. the period of 
time elapsed after the pretreatment of the rats with PMS and 
hCG. From pilot studies concerning the effect of the length 
of pseudo-pregnancy on the sensitivity of the OAAD-test 
(chapter 5 section 5. ,ί
л
 ) and from the reports by Parlou (1961) 
and Koch et al (1974) it may be inferred that the condition 
of pseudo-pregnancy was maintained constant during a number of 
days. However, the possibility of obscured day-to-day vari­
ations, e.g. in ovarian weight»condition of binding sites, 
which might have caused differences in the tissue preparations 
used cannot be excluded. 
From Table 8 - II it can be seen that the potency of LH 
preparations is lower than that of LH preparations. This 
could be explained by the fact that an LH preparation was 
used as tracer and it would be conceivable that LH rnolecules 
are less able than LH molecules to compete with labelled 
LH T T molecules for binding sites. Therefore, a control ex­
periment was done in which an LH. preparation was used as 
labelled hormone (Fig. 8 - 4). It appears that the difference 
in potency is not due to the type of LH used for labelling. 
Although it has been shown m Table 3 - III that the LH 
preparations show a considerable variation in subunit con­
tamination, this cannot be the explanation for the observed 
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Fig. 8 - 3 . Relationship between the type of LH used for labelling and 
the relative potencies of LH and LH in the radioligand assay. 
potency differences because a pertinent control study showed 
the subunits to be totally inactive in the RLA. This last 
result confirms similar conclusions by other investigators 
(Kammevman et al, 1972; Catt, Dufau & Tsuruhara, 1973). 
Finally, the sialic acid content, which is of great im­
portance for the in vivo biological activity, probably has 
also some influence, since it was shown that asialo-hCG was 
more active in the RLA than the native hormone (Tsuruhara 
et al, 1972; Kammerman et al, 1972; Lequin et al, 1975). 
Because the LH preparations have a lower sialic acid con­
tent than the LH- preparations (Table 3 - 1 ) this might ex­
plain that the potency of the LH T T preparations is higher. 
The last argument, however, does not hold for the preparations 
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from frozen glands (NM 10, 11) because no differences in 
sialic acid could be shown to exist. Concerning these batches 
there is yet another point. Comparison of the results of the 
batches NM 10 and 11 (frozen glands) with those of the other 
batches (acetone-dried glands) shows, both for LH and for 
LHIT, that the former have a lower potency, probably because 
they still contain an amount of inert protein. 
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CHAPTER 9. GENERAL DISCUSSION 
Purification of hormones to a high degree and subsequent de-
termination of the physico-chemical properties is compulsory 
for a complete understanding of their activity. It is, there-
fore, essential to remove contaminating hormones in order to 
avoid biases. Furthermore highly purified hormone preparations 
are necessary for developing assay methods e.g. for routine 
clinical purposes. The crucial, questions are: (1) What do we 
mean by a highly purified hormone preparation, and (2) Which 
other activities are exerted by such preparations that are 
selected on the basis of in v-Lvo biological activity. Trying 
to find an answer to these questions for human pituitary 
luteinizing hormone was the main purpose of this investigation. 
It appeared possible to isolate and purify LH from crude glyco-
protein material prepared from acetone-dried pituitary glands 
and from frozen pituitary glands. Besides the bulk fraction of 
LH isolated according to conventional methods a second fraction 
of LH, originally regarded as a contamination of the FSH 
fraction (Reiohert, 1967; Saxena & Rathnam, 1968; Butt, Crooke 
& Wolf, 1965; Graesslin, Weise & Bettendorf, 1972) could be 
isolated in substantial quantities and turned out to be an-
other form of LH. Both LH fractions, further referred to as 
LHT_ and LHT respectively, were almost completely free from 
the other pituitary glycoprotein hormones, namely FSH, as 
assessed by bioassay and radioimmunoassay, and TSH, as 
assessed by radioimmunoassay. The first question could in the 
first instance be answered as follows: a highly purified 
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hormone preparation is one that contains not more than 
negligable quantities of other hormones. In the purification 
of any protein one tries to remove selectively as much inert 
protein as possible, the success of which is reflected in the 
values for the specific activity after each step. Since a 
hormone is identified by its in *>¿vo biological activity, in 
hormone purification this type of activity is the basis for 
the above-mentioned purification. For most hormones the 
purification is regarded as completed when the specific 
biological activity cannot further be increased, i.e. when it 
reaches a plateau-value. However, in the case of glycoproteins 
the situation is more complicated. For these hormones the in 
vive biological activity is closely correlated to the content 
of the terminal carbohydrate, sialic acid (Van Hell, 
Matthijsen & Koman, 1068; Govcrde, Veenkamp & 'donan, 19CH; 
Sohuiirs j De Jager á Homan, IOCS; Van Hall, Vai tis.kai bis, Ross, 
Hiakman & Ashwell, 1971). Due to their proneness to loose part 
of the initial sialic acid content during purification, the 
theoretically maximal specific biological activity, which is 
orobably higher than the plateau-value, cannot be known for 
these hormones. As a consequence it is impossible to judge the 
"purity" of a preparation fron the measured specific biological 
activity only. In the second instance, for glycoproteins the 
answer to the first question may be extended as follows: a 
highly purified hormone preparation is one with a specific 
biological activity that is at least as high as the plateau-
value known by previous experience. Although the results for 
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the specific activities of the LH preparations reveal variation 
(Table 2 - I), in general these values can be regarded to be of 
the same order as those reported in the literature. The 
biological activity of a hormone is determined by one or more 
active sites of the molecule. Changes in the amino acid 
sequence which do not involve the active sites, therefore, do 
not necessarily change the function. This situation is the 
cause of the existence of different molecular forms of the 
same hormone. Thus, a hormone preparation may contain many 
molecular forms differing as to their amino acid composition 
and, in the case of glycoproteins, also as to their carbo-
hydrate composition, especially sialic acid content as 
mentioned earlier. The physico-chemical properties of such 
molecular forms, accordingly, also may show considerable 
variation, which would becoitevisible when a hormone preparation 
is subjected to e.g. isoelectric focussing. 
A so-called highly purified hormone preparation may turn 
out to be heterogeneous. This was found to be the case for the 
human LH preparations used in this investigation (chapter 3) 
as well as for LH preparations from several other species 
(Reichert, 1971). When Roos, Nyberg, Wide & Gemzell (1975) 
submitted a highly purified human LH preparation to Polyacryl-
amide electrophoresis, four components could be isolated and 
characterized. In a number of analyses these four components 
appeared to be homogeneous. Moreover, microheterogeneity 
beyond the limits of resolution cannot be excluded. In con-
clusion, the answer to the first question cou]d be adjusted as 
follows: a highly purified hormone preparation is one that 
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does not show any heterogeneity. 
If somebody would be succesful in obtaining an LU pre-
paration that meets the criteria mentioned above, he then 
might wonder to what extent this preparation represents the 
in vivo circulating hormone. This is important to know when 
experiments using the LH preparation are to be interpreted 
for the in vivo situation. The traditional concept that the 
pituitary gland secretes one molecular form of each hormone 
must be abandoned. The notion of normal variability in LH is 
also supported by the results of a study by Pobertson, Van 
Damme & Diczfalusy (1975). From this investigation it may be 
inferred that a variety of LH forms exists in a single 
pituitary gland. There exists also a second type of varia-
bility. From studies in the monkey and the rat (Bogdanove, 
Nolin & Campbell, 1975; Peckham, Yaniaji, Diersahke & Knobil, 
19 7 3) it may be concluded that the pituitary gland modulates 
i.e. secretes different molecular forms of a hormone in 
relation to the endocrine status of the body. These authors 
demonstrated a relationship between the behaviour of pituitary 
FSH on gelfiltration columns and the existing or induced 
endocrine condition of the animals. This last concept suggests 
that LH in prepubertal children may differ from that in peopln 
in the reproductive age which in turn may differ from that in 
aged people, but also that sex-linked differences may occur. 
In this respect, ICSH (interstitial cell-stimulating hormone) 
in the male and LH in the female might well be considered to 
be different molecular forms of the same hormone. 
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The same concept may also imply, that certain in-
fertility syndromes can be carried back to deviations in the 
molecular hormone structure. Consider, for instance, the 
Klinefelter syndrome. The pituitary gland of patients suffer-
ing from this chromosomal disorder, secrete large amounts of 
LH (ICSH) that can be measured by in vivo bioassays as well 
as by RIA, but the testosterone production is impaired. The 
Leydig cell function can be restored, however, by injection 
of hCG (Smals, Kloppenborg & Benraad, 1974). This indicates 
that the molecular form(s) of the patient's own LH (ICSH) are 
not suitable to pass the message to the Leydig cells. 
This second type of variability, related to age or 
general endocrine condition, could well be responsible for the 
presence of multiple LH forms in purified preparations from 
pituitary glands. It is, however, difficult to avoid such 
variability, since the supply of glands is limited and often 
the exact sources are not known. Commonly, these glands are 
from elderly people, as was the case for our batches. A third 
variable is induced through the techniques themselves: pre-
servation conditions as well as isolation and purification 
procedures. This is illustrated by the result of our own in-
vestigation showing differences between LH preparations ob-
tained from acetone-dried and frozen material. 
Furthermore, in comparing the hormone preparation with 
the in vivo circulating hormone also the peripheral metabolism 
must be taken into account. From recent reports in the 
literature on gelfiltration studies as well as from 
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observations in our own laboratory it might be inferred that 
in the blood the hormone is associated with proteins of various 
sizes (Leidenberger, Gvaesslin, Scheel, Hess, Ыа^.ьспЪе д & 
Bettendovf, 1976; Graesslin> Leiilenbevger·
 3 Lichtenberg 3 
Glisman, Hess, Czygan S Bettendovf, 1976; Lequin, 197C). 
Finally, it has been shown that also free hormoïie subunits 
circulate in the blood (henver.is tp
 3 Bell, Koeppel S Pabinowi tz 3 
1973; Prentice S Ryan, 1375; Hagen, ì'ciìatty & VcNpilly, 1970). 
In summary, it may be concluded that it is not justified to 
measure blood hormone levels, (usually done by radioimmunoassay) 
in terms ôf a standard preparation purified from pituitary 
glands. According to the principle of comparing "like" with 
"like", instead of a pituitary preparation, a serum pool 
should be used (Jeffcoate S Hutchinson, 1971; Bangham S Cotes, 
1974). If this is not feasible one might consider using a 
standard preparation obtained by a purification procedure 
oased on the activity in the radioimmunoassay instead of a 
procedure based on the activity in an in vivo bioassay. This 
is already practice for hormones for which no in υίύο bioassay 
is known to exist, e.g. human placental lactogen, or for the 
subunits of the glycoprotein hormones. 
From the foregoing it follows that for a complete 
elucidation of the effect of a hormone, including its 
mechanism of action, pertinent preparations should be 
characterized by as many assay methods as are available, in 
addition to the in vivo bioassay. Bearing this in mind and 
applying it to the human LH preparations of this investigation, 
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the second question (which other properties can be recognized?) 
may now be answered. Nowadays, at least three such additional 
methods are at one's disposal, namely гп vitro bioassay, radio­
immunoassay and radioligand assay. (Recently a new method, the 
cytochemical assay, has been developed and so far has been 
used successfully for the measurement of ACTH, TSH and gastrin; 
preliminary results indicate that it may also be applied for LH 
measurement (Chayen, 1976). Since this method was not available 
to us we shall leave it out of this discussion} In the chapters 
5 - 8 the results of these three methods as well as those of 
the in vivo bioassay have been presented. The LH preparations 
could be divided into four groups: a. LH from acetone-dried 
glands; b. LHj- from acetone-dried glands; c. LHT from frozen 
glands; d. LHj- from frozen glands. Since each preparation was 
purified from a batch of several thousands of pituitary glands, 
the presence of multiple molecular forms in each preparation 
is possible. Because the batches themselves had been composed 
in a similar way (mainly of glands from elderly people) it is 
highly probable that the above-mentioned variability was the 
same in all batches. Therefore, it was felt permissible to 
combine the results of all preparations belonging to the same 
group. For convenience, the combined values for the potencies 
are summarized in Table 9 - I. 
From these figures the following conclusions may be 
drawn : 
(1) For all assay methods the preparations from frozen glands 
show lower values than the corresponding preparations from 
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Table 9 - 1 . Comparison of LH and LH potencies obtained by d i f f e r e n t 
assay methods. 
ш
і 
Ш
І І 
ш
і 
L Hii 
acetone-
dried 
acetone-
dried 
frozen 
frozen 
in ai jo 
bioassay 
IU l S tIRP 
LH bio/mg 
7400 
(6370-8710) 
5650 
(4940-6480) 
'42 80 
(2830-6150) 
3830 
(1480-6920) 
гп nitro 
bioassay 
IU lStIRP 
LH bio/mg 
RIA 
IU lStIRP 
LH imm/mg 
(mean, 95% fiducial limits) 
?620 
(1920-3490) 
4190 
(3060-5680) 
2060 
(1780-2640) 
3610 
(2720-4880) 
1900* 
(1670-2210) 
3000* 
(2790-3300) 
810* 
(750-890) 
2040* 
(1460-2680) 
RLA 
IU lStIRP 
LH bio/mg 
6200* 
(5700-6800) 
17400* 
(16300-19000 
4800* 
(4200-5500) 
12000* 
(10300-13200 
* i n d i c a t e s s i g n i f i c a n t di f ference between LH and LH prepared from 
tne same source. 
a c e t o n e - d r i e d g l a n d s . I t i s c o n c e i v a b l e t h a t t h e e a r l i e r 
ment ioned p l a t e a u - v a l u e of t h e s p e c i f i c a c t i v i t i e s f o r t h e 
former i s lower t h a n t h a t f o r t h e l a t t e r . However, i t i s a l s o 
p o s s i b l e t h a t t h e p u r i f i c a t i o n p r o c e d u r e used i s n o t adequate 
t o c o m p l e t e l y remove t h e r e l a t i v e l y l a r g e amount of i n e r t 
p r o t e i n s t h a t o c c u r m f rozen g l a n d s . 
(2) LH and LHT T a r e d i f f e r e n t moleculen e n t i t i e s . T h e i r 
d i f f e r e n c e s c o n c e r n i n g гп г о and гп vitro b i o l o g i c a l 
a c t i v i t y may n o t be s i g n i f i c a n t , t h o s e r e v e a l e d by t h e RIA and 
t h e RLA d e f i n i t e l y a r e s i g n i f i c a n t . This c o n c l u s i o n i s in 
agreement w i t h t h e r e s u l t s of t h e p h y s i c o - c h e m i c a l 
c h a r a c t e r i z a t i o n , namely t h e l a r g e d i f f e r e n c e s i n p i - v a l u e 
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and К -value, and smaller differences in amino acid compo­
sition and sialic acid content. 
The most important observation concerns the "discrepancy" 
between the potencies determined by the bioassay fin vivo and 
in vitro) on the one hand, and those assessed by the RIA and 
the RLA on the other hand. According to the former assays, 
LH and LH _ have the same potency, but judged by the latter 
methods, LH is more potent than LHT. The question arises how 
this discrepancy might be explained. Bioassays measure bio­
logical effects of LH. In contrast, in RIA and RLA reactive 
parts of the hormone molecules are quantified: in the RIA these 
parts concern immunologically reactive sites and in the RLA 
they regard binding sites, i.e. parts responsible for binding 
the hormone to the cell membrane of the target tissue. There­
fore, the fact that in the RIA as well as in the RLA, LH-- is 
more potent than LH- indicates that LH-- has a greater 
aftinity for the antibody and also for the membrane site than 
LHT. The difference in affinity between LH and LH can also 
be deduced from the results of the experiments shown in Fig. 
7 - 3 and θ - 3. Irrespective of the type of LH used for 
labelling in these experiments, LH
 T is more potent than LH . 
This notion, naturally, is of particular significance 
with regard to the RLA as the binding of the hormones to the 
receptor is a necessary step in eliciting a biological 
response such as observed in the bioassays. That LH and LH--, 
nevertheless, do not differ in the bioassays would seem to be 
contradictory and opposing the view of those who regard the 
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RLA as a bioassay (bharpc, Shamancsh, Δ Lljood, llavbog & Broon, 
197ь; Sohlamowzt?, Cyonq^ft, "jfohani & Ward> 1076). While 
there is a lack of information about the kinetics of hormone 
binding (association and dissociation) and of the significance 
of affinity for the ultimate physiological response of the 
target cell, recent investigations yielded interesting 
pertinent information. Cna/>ring 4 . safvivi '197/) suggested 
the possibility that 1 - 10% of the binding sites on the cell 
membrane are required for the activation of the physiological 
process, and that these were of very high affinity, while 90 -
99% of the binding sites serve as a storage depot. Similarly, 
Catt & Dufau (197 3) studying the effect of hCG on the testis, 
showed that occupation of only a small part of the binding 
sites on the target was sufficient to elicit a maximal 
testosterone production. They introduced the term "spare 
receptors" to describe the unoccupied binding sites. Applying 
a similar reasoning to the LH bioassays used in this investi­
gation leads to the hypothesis that to elicit a response 
(OAAD and cAMP) occupation of only a small fraction of the 
binding sites is sufficient and that, as a consequence, the 
suspected affinity difference between LH and LH _ is unnoticed, 
unless this difference is very large. 
The above concept has its implications for clinical 
endocrinology. Since the amount of hormone in scrum and urine 
samples as a rule is too low to be measured by a proper гг> 
гоо bioassay, routinely the RIA is applied (although some 
investigators have stept over to RLA). Recently, also ьп vi, tro 
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bioassay capable of handling clinical samples have been re-
ported. The first results indeed indicate discrepancies 
between measurements by -in vitro bioassay and by RIA (Van 
Damme, Robertson & Diczfalusy, 1974; Du fau. Pook, Neubauer S 
Catt, 1976). Although in practice, the RIA has proved to be 
a useful tool in clinical endocrinology, the clinician should 
be aware of the possibility that the immunologically measured 
hormone levels do not necessarily reflect the patient's real 
(patho-)physiological endocrine status, which - as far as we 
know - only can be due to biologically active hormones of 
hormone fragments. 
EPILOGUE 
"It is not my intention to prove that until now I have been 
right, but to find out if I have been. Yes, we will make 
everything dubious and uncertain again. We shall not progress 
with seven-league boots but rather at a snail's pace. What-
ever we find today should be erased tomorrow .... and be re-
written only after due reassessment. And should we find a 
hypothesis of ours to be correct we will regard it with 
particular suspicion." 
(Bertolt Brecht, Galileo Galilae) 
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SUMMARY 
Luteinizing hormone was purified from human pituitary glands. 
The preparations were characterized by a number of parameters 
concerning structure and function. 
In chapter 1 the backgrounds and motives for this 
investigation are reviewed. 
The purification procedure for crude glycoprotein 
material from acetone-dried pituitary glands as well as from 
frozen glands is outlined in chapter 2. By a series of ion-
exchange chromatography steps the bulk quantities of LH 
(coded LH ), FSH and TSH were separated from each other. Yet, 
the FSH fraction still contained a substantial amount of LH. 
This type of LH (coded LH ) could be isolated by further ion-
exchange chromatography of the FSH-fraction. Both LH-fractions 
were then further purified by gelfiltration on Sephadex G 100 
and lyophilized. The final preparations were only minimally 
contaminated by FSH and TSH as was shown by bioassay and 
radioimmunoassay determinations (chapters 5 and 7). The LH 
and LHTT preparations thus obtained from each batch of 
pituitary material were compared in the ensuing characterization 
studies. 
In chapter 3 some physico-chemical properties are dis-
cussed. Microheterogeneity in all preparations was indicated 
by the finding of more than one band in isoelectric focussing 
studies. LH and LH appeared to differ as to their iso-
electric point, sialic acid content, amino acid composition 
and molecular size. The contamination of each preparation by 
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free LH-subunits was determined. From the combined results 
it was concluded that LH and LH T T are different molecular 
entities. 
Chapter 4 introduces the assay methods (which are described 
in more detail in the following chapters) as well as some. 
theoretical considerations about the validity and reliability 
of these methods. 
The in υίυο bioassays are described in chapter 5. The 
LH preparations have been tested extensively in the ovarian 
ascorbic acid (OAAD) method. It was felt pertinent to carry 
out also a number of determinations with the seminal vesicle 
weight (SVW) test since it has been shown, at least for hCG, 
that acute (OAAD) and chronic (SVW) tests may yield different 
results. Both methods showed that for acetone-dried material 
LH. is slightly more active than LH ; for frozen material no 
differences could be observed between LH and LH preparations. 
In chapter 6 the in vitro bioassay is described. To avoid 
the need of using enzymatic treatment for dispersion of the 
tissue, a cell type, which is by nature already in suspension, 
was selected, namely granulosa cells from immature pigs. LH-
induced progesterone production was taken as an end-point. 
However, although the progesterone production was increased 
when LH was present in the medium, the dose-response curve was 
erratic. Thereupon, instead of granulosa cells, intact medium-
sized porcine follicles were tried. Again, no quantitative 
relationship between the dose of LH and the progesterone 
production could be established. Therefore, the cAMP production 
was taken as end-point instead. Although this system could be 
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used to measure ьп vztro LH activity, it proved to be a rather 
imprecise method because of the difficulty to circumvent 
variation in maturity of the follicles. The results showed no 
significant difference in activity between LH and LH 
preparations. 
The radioimmunoassay is discussed in chapter 7. To avoid 
possible interference of the other glycoprotein hormones on 
the basis of similarity of the α-subunits, the assay systems 
used employed an antiserum raised against highly purified LH.. 
P 
Besides the standard LH.-system a quick LHR-system was 
developed mainly as a tool in the purification procedure, for 
monitoring the effluent of the chromatography and gel-
filtration columns. This quick system employs a higher con­
centration of tracer and antiserum and is carried out at 37 C. 
All preparations were tested in both LH -systems. The LH 
preparations showed consistently lower activities than the LH T T 
preparations. Preparations from frozen glands had a lower 
activity than those from acetone-dried glands. Several possible 
explanations were discussed. Comparison of the results of each 
preparation obtained in standard and quick system led to the 
interesting discovery that LH preparations in solution are un­
stable at 37 С and that some dissociation into subunits then 
occurs. 
In chapter 8 the radioligand assay is dealt with. A 
homogenate of ovaries from pseudo-pregnant rats was used as 
binding tissue. Although this assay system was somewhat less 
precise than the RIA the results were essentially the same: 
the LH preparations were less active than the LH-- preparations 
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and the preparations from frozen glands were less active than 
those from acetone-dried glands. 
The general discussion (chapter 9) is divided in two 
parts. The first part deals with the problem of heterogeneity 
of hormone preparations and the presence of various molecular 
forms. It was concluded that it is essential to characterize 
highly purified hormone preparations by as many methods as 
possible; this enables the investigator to rate the experi-
mental results designed to elucidate the mechanism of action 
at their proper value. The second part concerns a comparison 
of the results of the four assay methods used for the 
determination of the various activities in the LH preparations. 
It was concluded that the functional assay methods (in vivo 
and in vitro bioassay) and the structural assay methods (RIA 
and RLA) measure different activities. The opinion of some 
investigators that the RLA is to be regarded as a bioassay, 
is contradicted. 
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SAMENVATTING 
Luteiniserend hormoon werd gezuiverd uit menselijke hyoofysen. 
De verkregen preparaten werden gekarakteriseerd door middel 
van een aantal parameters betreffende structuur and functie. 
In hoofdstuk 1 wordt de vraagstelling, die leidde tot dit 
onderzoek, geïntroduceerd. 
De zuiveringsprocedure voor ruw glycoproteinen materiaal 
afkomstig van aceton-gedroogde hypofysen en van bevroren hypo-
fysen is beschreven in hoofdstuk 2. Door middel van een reeks 
chromatografie - stappen over lonenwisselaars konden het groot-
ste deel van het LH (code LH-r-,) / het FSH en het TSH van elkaar 
gescheiden worden. Toch bevatte de ruwe FSH-fractie nog een 
aanzienlijke hoeveelheid LH. Dit type LH (code LH ) kon door 
middel van verdere chromatografie over een lonenwisselaar van 
het FSH gescheiden worden. Beide LH-fracties werden verder ge-
zuiverd door middel van gelfiltratie over Sephadex G 100 en 
tenslotte drooggevroren. De emd-preparaten bevatten slechts 
minimale contaminaties van FSH en TSH zoals via bioassay resp. 
immunoassay kon worden aangetoond.(zie hoofdstukken 5 en 7). 
De verkregen LH en LH
 T preparaten werden vergeleken in ver-
dere karakterisenngsproeven. 
In hoofdstuk 3 wordt een aantal fysisch-chemische eigen-
schappen behandeld. Het voorkomen van microheterogeniteit in 
alle preparaten werd afgeleid uit de aanwezigheid van een 
aantal verschillende banden in isoelectnsche focussenngs-
studies. Tussen LH en Lil bleken verschillen te bestaan wat 
betreft isoelectrisch punt, siaalzuurgehalte, aminozuursamen-
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stelling en molecuulgrootte. De contaminatie van vri;je LH-
subunits in de preparaten werd ook bepaald. Alle resultaten 
tezamen leidden tot de conclusie dat LH en LH verschillende 
moleculaire eenheden zi^n. 
In hoofdstuk 4 worden de bepalircrspethoden geïntroduceerd, 
die m de volgende hoofdstukken uitgebreider besproken worden. 
Tevens worden theoretische aspecten over de waarde en betrouw-
baarheid van deze methoden belicht. 
De гп vivo bioassays zijn beschreven m hoofdstuk 5. De 
LH preparaten zijn uitgebreid getest met behulp van de ovari-
ele ascorbinezuur depletie (OAAD) methode. Een aantal LH-be-
palingen werd ook uitgevoerd met de zaadblaasgewichtstoename 
(SVW) test, omdat was aangetoond, althans van hCG, dat in 
kortdurende (OAAD) en chronische (SVW) methoden verschillende 
uitkomsten gevonden worden. Met beide methoden werd gevonden 
dat LH van aceton-gedroogde hypofysen iets actiever is dan 
LH--; tussen LH en LH preparaten van bevroren materiaal 
werden geen verschillen gevonden. 
In hoofdstuk 6 wordt de in vitro bioassay beschreven. 
Om het gebruik van enzymen, nodig voor de dispersie van het 
weefsel, te vermijden werd een celtype uitgekozen dat van 
nature al in suspensie is, namelijk granulosacellen van imma­
ture varkens. De door de LH geïnduceerde progesteronproduktie 
werd als eindpunt genomen. Hoewel de progesteronproduktie toe-
nam wanneer het medium LH bevatte, was de dosis-responsie 
curve zeer onregelmatig. Daarom werden, in plaats van granu-
losacellen, intacte middelgrote varkensfollikels geprobeerd. 
Opnieuw bleek er geen kwantitatief verband te bestaan tussen 
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de dosis LH en de progesteronproduktie. Daarom werd de сЛМР-
produktie gekozen. Met dit systeem bleek het mogelijk de г с 
vitro LH-activiteit te meten maar de methode bleek weinig pre­
cies te zi^n. De moeilijkheid was om de variatie in de rijp­
heid van de follikels te vermijden. Uit de resultaten bleek dat 
er geen significant verschil ¿n activiteit bestond tussen IiHT 
en LH preparaten. 
De radioimmunoassay wordt besproken in hoofdstuk 7. Om te 
voorkomen dat de andere glycoproLeme hormonen OD basis van 
de gelijkheid van de a-subunits zouden interfereren, werd m 
de assaysystemen gebruik genaakt van een antiserum opgewekt 
tegen hooggezuiverd LH . Behalve het standaard LH -systeem 
werd een snel LH -systeem ontwikkeld in hoofdzaak als hulp-
middel bij de zuiveringsmethode, namelijk om het eluaat van 
de cnromatografie en gelfiltratie kolommen snel te kunnen door-
meten. In dit snelle systeem wordt een hogere concentratie 
tracer en antiserum gebruikt en de incubatie vindt plaats bij 
37 C. Alle preparaten werden m beide LH -systemen bepaald. 
De LH preparaten vertoonden steeds een lagere activiteit dan 
de LH preparaten. Ook hadden preparaten gemaakt uit bevro-
ren hypofysen een lagere activiteit dan die, gemaakt uit ace-
ton-gedroogde hypofysen. Een paar mogelijke verklaringen hier-
voor worden besproken. Bij het vergelijken van de resultaten 
van elk preparaat in het standaard en het snelle systeem werd 
de interessante ontdekking gedaan dat LH preparaten in oplos-
sing onstabiel zijn bij hogere temperatuur (37 C) en dat er 
spontane dissociatie in subumts plaatsvindt. 
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In hoofdstuk 8 wordt de radioligand assay besproken. Een 
homogenaat van ovaría van pseudozwangere ratten werd gebruikt 
als bindend weefsel. Ofschoon deze methode iets minder precies 
is dan de RIA waren de resultaten vrijwel hetzelfde: de LH 
preparaten waren minder actief dan de LH preparaten en de 
preparaten bereid uit bevroren hypofysen waren minder actief 
dan die, bereid uit aceton-gedroogde hypofysen. 
De algemene discussie (hoofdstuk 9) valt uiteen in twee 
t 
stukken. In het eerste deel wordt de problematiek van de hete-
rogeniteit van hormoonpreparaten en de aanwezigheid van tal-
rijke moleculaire vormen besproken. Geconcludeerd werd dat 
het van belang is om de hooggezuiverde hormoonpreparaten te 
karakteriseren met behulp van zoveel mogelijk methoden; dit 
geeft de onderzoeker een beter inzicht hoe de experimentele 
resultaten bij de opheldering van het werkingsmechanisme ge-
waardeerd moeten worden. In het tweede deel worden de resul-
taten besproken van de vier bepalingssystemen die gebruikt 
zijn om de verschillende activiteiten van de LH preparaten te 
meten. Als conclusie komt naar voren dat de "functionele" bepa-
lingsmethoden (гп vivo en in vitro bioassay) en de "structurele" 
(RIA en RLA) verschillende dingen meten
;
hetwelk in tegenspraak 
is met de mening van diegenen die de RLA beschouwen als een 
bioassay. 
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STELLINGEN 
Bij het onderzoek naar het werkingsmechanisme van eiwithormo-
nen, dient men bij de interpretatie van de resultaten rekening 
te houden met heterogeniteit van de gebruikte "hoog gezuiverde" 
preparaten. 
(Dit proefschrift) 
Ten onrechte wordt door sommige onderzoekers de radioligand 
assay beschouwd als een bioassay. 
(Schlamowitz M., Cronquist J., Esfahani M. & Ward D.N. (1976) Acta Endocr. 
(Kbh) 81, 270; Sharpe R.M., Shamanesh M., Ellwood M.G., Hartog M. & 
Brown P.S. (1975) J. Endocr. 65, 265) 
De door de lUPAC-Commission on Biochemical Nomenclature aan-
bevolen namen voor peptide hormonen dragen, in tegenstelling 
tot het beoogde doel, niet bij tot duidelijkheid in de naam-
geving. 
(The nomenclature of peptide hormones (1975) J. 3iol. Chem. 250, 3215) 
Om te voorkomen, dat voor de in de toekomst vast te stellen 
internationale standaarden en referentie-preparaten de be-
staande verwarring met betrekking tot de eenheden van biolo-
gische en immunologische activiteit voortduurt, dient de WHO 
Expert Committee on Biological Standardization terug te komen 
op haar besluit om deze twee soorten eenheden in getalswaarde 
zoveel mogelijk aan elkaar gelijk te kiezen. 
(WHO - ECBS 21th Report (1969) WHO Techn. Rep. Ser. 413, 8) 
Het na de dood afstaan van organen ten behoeve van transplan-
tatie of isolatie van anderszins niet te verkrijgen componen-
ten moet beschouwd worden als een plicht jegens de medemens. 
De wettelijke regeling op dit punt dient verbeterd te worden. 
(C.F. Wery, Beschikken over eigen lichaam. Ars Aequi XXV p. 305) 
Het vermelden van de activiteit van een testis carcmoom in 
hoeveelheden humaan chorion gonadotropine (hCG) per ml serum 
is onjuist omdat hCG per definitie afkomstig is van іасегіагг 
trofoblastweefsel. 
Door de van oudsher autoritaire positie en de daaruit voort­
vloeiende mentale instelling van de arts is er een gerede kans 
dat de relatie clinicus - niet clinicus,bi] het bepalen van 
het gezamenlijk te voeren beleid in multidisciplinaire onder­
zoeksprojecten, negatief beïnvloed wordt. 
Artikel 2 3 van de Promotieregeling vormt een inbreuk op de 
vrijheid van meningsuiting; deze inbreuk is slechts mogelijk 
op grond van het feit dat de Katnolieke Universiteit Nijmegen 
formeel geen overheidsinstelling maar een stichting is. 
(P.J. Boukema, Enkele aspecten van de vrijheid van meningsuiting in de 
Duitse Bondsrepubliek en in Nederland. Alpaen a/d Ri]n (1967) p. 219 ev) 
Voor het efficient verrichten van wetenschappelijk onderzoek 
is een goed georganiseerde wetenschappelijke bibliotheek on-
misbaar. 
De gynaecoloog, die m het kader van de diagnostiek van m -
fertiliteit een pakket van onderzoekingen opstelt, realiseert 
zich vaak onvoldoende in welke mate de inspanningen, die de 
echtelieden zich in deze moeten getroosten, een verstoring van 
de sexuele relatie ten gevolge kunnen hebben. 
Teneinde een werkelijke belangenbehartiging van de burgers 
te waarborgen, verdient het aanbeveling dat de overheid bij 
het uitvoeren van openbare werken de Wet op de Ruimtelijke 
Ordening met grotere zorgvuldigheid in acht neemt. 
Gezien de talrijke problemen van psychische en fysieke aard, 
die de voortplanting bij de mens kan veroorzaken, moeten de 
kabouters beschouwd worden als fortuinlijke wezens. 
(W. Huygen en R. Poortvliet, Leven en werken van de kabouter. Van Holkema 
& Warendorf, Bussum) 
De polemiek, die pleegt te ontstaan na een Oudejaarsavond-
conference van Wim Kan, getuigt van een gebrek aan gevoel 
voor humor bij het Nederlandse volk. 
J.G. Loeber 
22 april 1977 



